id	sid	tid	token	lemma	pos
cord-024716-1waejlwb	1	1	key	key	JJ
cord-024716-1waejlwb	1	2	:	:	:
cord-024716-1waejlwb	1	3	cord-024716	cord-024716	NN
cord-024716-1waejlwb	1	4	-	-	HYPH
cord-024716-1waejlwb	1	5	1waejlwb	1waejlwb	CD
cord-024716-1waejlwb	1	6	authors	author	NNS
cord-024716-1waejlwb	1	7	:	:	:
cord-024716-1waejlwb	1	8	Roy	Roy	NNP
cord-024716-1waejlwb	1	9	,	,	,
cord-024716-1waejlwb	1	10	Soumya	Soumya	NNP
cord-024716-1waejlwb	1	11	title	title	NN
cord-024716-1waejlwb	1	12	:	:	:
cord-024716-1waejlwb	2	1	Does	do	VBZ
cord-024716-1waejlwb	2	2	the	the	DT
cord-024716-1waejlwb	2	3	Bacillus	Bacillus	NNP
cord-024716-1waejlwb	2	4	Calmette	Calmette	NNP
cord-024716-1waejlwb	2	5	–	–	:
cord-024716-1waejlwb	2	6	Guérin	Guérin	NNP
cord-024716-1waejlwb	2	7	vaccine	vaccine	NN
cord-024716-1waejlwb	2	8	provide	provide	VBP
cord-024716-1waejlwb	2	9	protection	protection	NN
cord-024716-1waejlwb	2	10	from	from	IN
cord-024716-1waejlwb	2	11	COVID-19	COVID-19	NNP
cord-024716-1waejlwb	2	12	?	?	.
cord-024716-1waejlwb	3	1	date	date	NN
cord-024716-1waejlwb	3	2	:	:	:
cord-024716-1waejlwb	3	3	2020	2020	CD
cord-024716-1waejlwb	3	4	-	-	HYPH
cord-024716-1waejlwb	3	5	04	04	CD
cord-024716-1waejlwb	3	6	-	-	SYM
cord-024716-1waejlwb	3	7	30	30	CD
cord-024716-1waejlwb	3	8	journal	journal	NN
cord-024716-1waejlwb	3	9	:	:	:
cord-024716-1waejlwb	4	1	Indian	Indian	NNP
cord-024716-1waejlwb	4	2	J	J	NNP
cord-024716-1waejlwb	4	3	Med	Med	NNP
cord-024716-1waejlwb	4	4	Sci	Sci	NNP
cord-024716-1waejlwb	4	5	DOI	DOI	NNP
cord-024716-1waejlwb	4	6	:	:	:
cord-024716-1waejlwb	4	7	10.25259	10.25259	CD
cord-024716-1waejlwb	4	8	/	/	SYM
cord-024716-1waejlwb	4	9	ijms_37_2020	ijms_37_2020	:
cord-024716-1waejlwb	4	10	sha	sha	NNP
cord-024716-1waejlwb	4	11	:	:	:
cord-024716-1waejlwb	4	12	33a2e1453144e432f8b2c933c09d016b41186439	33a2e1453144e432f8b2c933c09d016b41186439	NNP
cord-024716-1waejlwb	4	13	doc_id	doc_id	CD
cord-024716-1waejlwb	4	14	:	:	:
cord-024716-1waejlwb	4	15	24716	24716	CD
cord-024716-1waejlwb	4	16	cord_uid	cord_uid	NNS
cord-024716-1waejlwb	4	17	:	:	:
cord-024716-1waejlwb	5	1	1waejlwb	1waejlwb	CD
cord-024716-1waejlwb	5	2	OBJECTIVE	objective	NN
cord-024716-1waejlwb	5	3	:	:	:
cord-024716-1waejlwb	6	1	The	the	DT
cord-024716-1waejlwb	6	2	novel	novel	JJ
cord-024716-1waejlwb	6	3	coronavirus	coronavirus	NN
cord-024716-1waejlwb	6	4	pandemic	pandemic	NN
cord-024716-1waejlwb	6	5	is	be	VBZ
cord-024716-1waejlwb	6	6	ravaging	ravage	VBG
cord-024716-1waejlwb	6	7	throughout	throughout	IN
cord-024716-1waejlwb	6	8	the	the	DT
cord-024716-1waejlwb	6	9	world	world	NN
cord-024716-1waejlwb	6	10	.	.	.
cord-024716-1waejlwb	7	1	It	-PRON-	PRP
cord-024716-1waejlwb	7	2	has	have	VBZ
cord-024716-1waejlwb	7	3	infected	infect	VBN
cord-024716-1waejlwb	7	4	more	more	JJR
cord-024716-1waejlwb	7	5	than	than	IN
cord-024716-1waejlwb	7	6	1.2	1.2	CD
cord-024716-1waejlwb	7	7	million	million	CD
cord-024716-1waejlwb	7	8	people	people	NNS
cord-024716-1waejlwb	7	9	and	and	CC
cord-024716-1waejlwb	7	10	killed	kill	VBD
cord-024716-1waejlwb	7	11	more	more	JJR
cord-024716-1waejlwb	7	12	than	than	IN
cord-024716-1waejlwb	7	13	64,000	64,000	CD
cord-024716-1waejlwb	7	14	.	.	.
cord-024716-1waejlwb	8	1	Frantic	frantic	JJ
cord-024716-1waejlwb	8	2	research	research	NN
cord-024716-1waejlwb	8	3	is	be	VBZ
cord-024716-1waejlwb	8	4	underway	underway	JJ
cord-024716-1waejlwb	8	5	to	to	TO
cord-024716-1waejlwb	8	6	find	find	VB
cord-024716-1waejlwb	8	7	prevention	prevention	NN
cord-024716-1waejlwb	8	8	and	and	CC
cord-024716-1waejlwb	8	9	cure	cure	NN
cord-024716-1waejlwb	8	10	.	.	.
cord-024716-1waejlwb	9	1	Of	of	IN
cord-024716-1waejlwb	9	2	late	late	RB
cord-024716-1waejlwb	9	3	,	,	,
cord-024716-1waejlwb	9	4	Bacillus	Bacillus	NNP
cord-024716-1waejlwb	9	5	Calmette	Calmette	NNP
cord-024716-1waejlwb	9	6	–	–	:
cord-024716-1waejlwb	9	7	Guérin	Guérin	NNP
cord-024716-1waejlwb	9	8	(	(	-LRB-
cord-024716-1waejlwb	9	9	BCG	BCG	NNP
cord-024716-1waejlwb	9	10	)	)	-RRB-
cord-024716-1waejlwb	9	11	has	have	VBZ
cord-024716-1waejlwb	9	12	been	be	VBN
cord-024716-1waejlwb	9	13	speculated	speculate	VBN
cord-024716-1waejlwb	9	14	as	as	IN
cord-024716-1waejlwb	9	15	a	a	DT
cord-024716-1waejlwb	9	16	possible	possible	JJ
cord-024716-1waejlwb	9	17	protection	protection	NN
cord-024716-1waejlwb	9	18	from	from	IN
cord-024716-1waejlwb	9	19	COVID-19	COVID-19	NNP
cord-024716-1waejlwb	9	20	.	.	.
cord-024716-1waejlwb	10	1	We	-PRON-	PRP
cord-024716-1waejlwb	10	2	sought	seek	VBD
cord-024716-1waejlwb	10	3	to	to	TO
cord-024716-1waejlwb	10	4	investigate	investigate	VB
cord-024716-1waejlwb	10	5	the	the	DT
cord-024716-1waejlwb	10	6	evidence	evidence	NN
cord-024716-1waejlwb	10	7	behind	behind	IN
cord-024716-1waejlwb	10	8	the	the	DT
cord-024716-1waejlwb	10	9	claim	claim	NN
cord-024716-1waejlwb	10	10	.	.	.
cord-024716-1waejlwb	11	1	MATERIAL	material	NN
cord-024716-1waejlwb	11	2	AND	and	CC
cord-024716-1waejlwb	11	3	METHODS	method	NNS
cord-024716-1waejlwb	11	4	:	:	:
cord-024716-1waejlwb	12	1	Data	datum	NNS
cord-024716-1waejlwb	12	2	were	be	VBD
cord-024716-1waejlwb	12	3	collected	collect	VBN
cord-024716-1waejlwb	12	4	regarding	regard	VBG
cord-024716-1waejlwb	12	5	the	the	DT
cord-024716-1waejlwb	12	6	total	total	JJ
cord-024716-1waejlwb	12	7	number	number	NN
cord-024716-1waejlwb	12	8	of	of	IN
cord-024716-1waejlwb	12	9	COVID-19	covid-19	JJ
cord-024716-1waejlwb	12	10	cases	case	NNS
cord-024716-1waejlwb	12	11	per	per	IN
cord-024716-1waejlwb	12	12	million	million	CD
cord-024716-1waejlwb	12	13	and	and	CC
cord-024716-1waejlwb	12	14	total	total	JJ
cord-024716-1waejlwb	12	15	number	number	NN
cord-024716-1waejlwb	12	16	of	of	IN
cord-024716-1waejlwb	12	17	COVID-19	covid-19	JJ
cord-024716-1waejlwb	12	18	deaths	death	NNS
cord-024716-1waejlwb	12	19	per	per	IN
cord-024716-1waejlwb	12	20	million	million	CD
cord-024716-1waejlwb	12	21	in	in	IN
cord-024716-1waejlwb	12	22	various	various	JJ
cord-024716-1waejlwb	12	23	countries	country	NNS
cord-024716-1waejlwb	12	24	.	.	.
cord-024716-1waejlwb	13	1	The	the	DT
cord-024716-1waejlwb	13	2	BCG	BCG	NNP
cord-024716-1waejlwb	13	3	vaccination	vaccination	NN
cord-024716-1waejlwb	13	4	policies	policy	NNS
cord-024716-1waejlwb	13	5	of	of	IN
cord-024716-1waejlwb	13	6	these	these	DT
cord-024716-1waejlwb	13	7	countries	country	NNS
cord-024716-1waejlwb	13	8	were	be	VBD
cord-024716-1waejlwb	13	9	also	also	RB
cord-024716-1waejlwb	13	10	obtained	obtain	VBN
cord-024716-1waejlwb	13	11	.	.	.
cord-024716-1waejlwb	14	1	RESULTS	result	NNS
cord-024716-1waejlwb	14	2	:	:	:
cord-024716-1waejlwb	15	1	It	-PRON-	PRP
cord-024716-1waejlwb	15	2	was	be	VBD
cord-024716-1waejlwb	15	3	seen	see	VBN
cord-024716-1waejlwb	15	4	that	that	IN
cord-024716-1waejlwb	15	5	the	the	DT
cord-024716-1waejlwb	15	6	countries	country	NNS
cord-024716-1waejlwb	15	7	with	with	IN
cord-024716-1waejlwb	15	8	no	no	DT
cord-024716-1waejlwb	15	9	universal	universal	JJ
cord-024716-1waejlwb	15	10	BCG	BCG	NNP
cord-024716-1waejlwb	15	11	policy	policy	NN
cord-024716-1waejlwb	15	12	had	have	VBD
cord-024716-1waejlwb	15	13	a	a	DT
cord-024716-1waejlwb	15	14	mean	mean	JJ
cord-024716-1waejlwb	15	15	1272.9	1272.9	CD
cord-024716-1waejlwb	15	16	(	(	-LRB-
cord-024716-1waejlwb	15	17	median	median	NN
cord-024716-1waejlwb	15	18	795	795	CD
cord-024716-1waejlwb	15	19	)	)	-RRB-
cord-024716-1waejlwb	15	20	cases	case	NNS
cord-024716-1waejlwb	15	21	per	per	IN
cord-024716-1waejlwb	15	22	million	million	CD
cord-024716-1waejlwb	15	23	and	and	CC
cord-024716-1waejlwb	15	24	80.7	80.7	CD
cord-024716-1waejlwb	15	25	deaths	death	NNS
cord-024716-1waejlwb	15	26	(	(	-LRB-
cord-024716-1waejlwb	15	27	median	median	NN
cord-024716-1waejlwb	15	28	18	18	CD
cord-024716-1waejlwb	15	29	)	)	-RRB-
cord-024716-1waejlwb	15	30	per	per	IN
cord-024716-1waejlwb	15	31	million	million	CD
cord-024716-1waejlwb	15	32	population	population	NN
cord-024716-1waejlwb	15	33	.	.	.
cord-024716-1waejlwb	16	1	On	on	IN
cord-024716-1waejlwb	16	2	the	the	DT
cord-024716-1waejlwb	16	3	contrary	contrary	NN
cord-024716-1waejlwb	16	4	,	,	,
cord-024716-1waejlwb	16	5	the	the	DT
cord-024716-1waejlwb	16	6	countries	country	NNS
cord-024716-1waejlwb	16	7	with	with	IN
cord-024716-1waejlwb	16	8	a	a	DT
cord-024716-1waejlwb	16	9	universal	universal	JJ
cord-024716-1waejlwb	16	10	BCG	BCG	NNP
cord-024716-1waejlwb	16	11	vaccination	vaccination	NN
cord-024716-1waejlwb	16	12	policy	policy	NN
cord-024716-1waejlwb	16	13	had	have	VBD
cord-024716-1waejlwb	16	14	a	a	DT
cord-024716-1waejlwb	16	15	mean	mean	JJ
cord-024716-1waejlwb	16	16	131.2	131.2	CD
cord-024716-1waejlwb	16	17	(	(	-LRB-
cord-024716-1waejlwb	16	18	median	median	NN
cord-024716-1waejlwb	16	19	40	40	CD
cord-024716-1waejlwb	16	20	)	)	-RRB-
cord-024716-1waejlwb	16	21	cases	case	NNS
cord-024716-1waejlwb	16	22	per	per	IN
cord-024716-1waejlwb	16	23	million	million	CD
cord-024716-1waejlwb	16	24	and	and	CC
cord-024716-1waejlwb	16	25	4	4	CD
cord-024716-1waejlwb	16	26	deaths	death	NNS
cord-024716-1waejlwb	16	27	(	(	-LRB-
cord-024716-1waejlwb	16	28	median	median	JJ
cord-024716-1waejlwb	16	29	1	1	CD
cord-024716-1waejlwb	16	30	)	)	-RRB-
cord-024716-1waejlwb	16	31	per	per	IN
cord-024716-1waejlwb	16	32	population	population	NN
cord-024716-1waejlwb	16	33	.	.	.
cord-024716-1waejlwb	17	1	The	the	DT
cord-024716-1waejlwb	17	2	difference	difference	NN
cord-024716-1waejlwb	17	3	is	be	VBZ
cord-024716-1waejlwb	17	4	highly	highly	RB
cord-024716-1waejlwb	17	5	significant	significant	JJ
cord-024716-1waejlwb	17	6	(	(	-LRB-
cord-024716-1waejlwb	17	7	P	p	NN
cord-024716-1waejlwb	17	8	<	<	XX
cord-024716-1waejlwb	17	9	0.001	0.001	CD
cord-024716-1waejlwb	17	10	)	)	-RRB-
cord-024716-1waejlwb	17	11	.	.	.
cord-024716-1waejlwb	18	1	CONCLUSION	conclusion	NN
cord-024716-1waejlwb	18	2	:	:	:
cord-024716-1waejlwb	19	1	The	the	DT
cord-024716-1waejlwb	19	2	data	datum	NNS
cord-024716-1waejlwb	19	3	strongly	strongly	RB
cord-024716-1waejlwb	19	4	support	support	VBP
cord-024716-1waejlwb	19	5	the	the	DT
cord-024716-1waejlwb	19	6	hypothesis	hypothesis	NN
cord-024716-1waejlwb	19	7	that	that	IN
cord-024716-1waejlwb	19	8	BCG	BCG	NNP
cord-024716-1waejlwb	19	9	may	may	MD
cord-024716-1waejlwb	19	10	offer	offer	VB
cord-024716-1waejlwb	19	11	protection	protection	NN
cord-024716-1waejlwb	19	12	from	from	IN
cord-024716-1waejlwb	19	13	COVID-19	COVID-19	NNP
cord-024716-1waejlwb	19	14	.	.	.
cord-024716-1waejlwb	20	1	Heterologous	heterologous	JJ
cord-024716-1waejlwb	20	2	protection	protection	NN
cord-024716-1waejlwb	20	3	offered	offer	VBN
cord-024716-1waejlwb	20	4	by	by	IN
cord-024716-1waejlwb	20	5	BCG	BCG	NNP
cord-024716-1waejlwb	20	6	through	through	IN
cord-024716-1waejlwb	20	7	production	production	NN
cord-024716-1waejlwb	20	8	of	of	IN
cord-024716-1waejlwb	20	9	trained	train	VBN
cord-024716-1waejlwb	20	10	immunity	immunity	NN
cord-024716-1waejlwb	20	11	,	,	,
cord-024716-1waejlwb	20	12	epigenetic	epigenetic	JJ
cord-024716-1waejlwb	20	13	reprogramming	reprogramming	NN
cord-024716-1waejlwb	20	14	of	of	IN
cord-024716-1waejlwb	20	15	monocytes	monocyte	NNS
cord-024716-1waejlwb	20	16	,	,	,
cord-024716-1waejlwb	20	17	non	non	JJ
cord-024716-1waejlwb	20	18	-	-	JJ
cord-024716-1waejlwb	20	19	specific	specific	JJ
cord-024716-1waejlwb	20	20	activation	activation	NN
cord-024716-1waejlwb	20	21	of	of	IN
cord-024716-1waejlwb	20	22	NK	NK	NNP
cord-024716-1waejlwb	20	23	cells	cell	NNS
cord-024716-1waejlwb	20	24	,	,	,
cord-024716-1waejlwb	20	25	and	and	CC
cord-024716-1waejlwb	20	26	increase	increase	NN
cord-024716-1waejlwb	20	27	of	of	IN
cord-024716-1waejlwb	20	28	pro	pro	JJ
cord-024716-1waejlwb	20	29	-	-	JJ
cord-024716-1waejlwb	20	30	inflammatory	inflammatory	JJ
cord-024716-1waejlwb	20	31	cytokines	cytokine	NNS
cord-024716-1waejlwb	20	32	(	(	-LRB-
cord-024716-1waejlwb	20	33	particularly	particularly	RB
cord-024716-1waejlwb	20	34	,	,	,
cord-024716-1waejlwb	20	35	tumor	tumor	NN
cord-024716-1waejlwb	20	36	necrosis	necrosis	NN
cord-024716-1waejlwb	20	37	factor	factor	NN
cord-024716-1waejlwb	20	38	[	[	-LRB-
cord-024716-1waejlwb	21	1	TNF]-alpha	tnf]-alpha	CD
cord-024716-1waejlwb	21	2	and	and	CC
cord-024716-1waejlwb	21	3	interleukin	interleukin	NN
cord-024716-1waejlwb	21	4	1	1	CD
cord-024716-1waejlwb	21	5	beta	beta	NN
cord-024716-1waejlwb	21	6	)	)	-RRB-
cord-024716-1waejlwb	21	7	production	production	NN
cord-024716-1waejlwb	21	8	may	may	MD
cord-024716-1waejlwb	21	9	be	be	VB
cord-024716-1waejlwb	21	10	the	the	DT
cord-024716-1waejlwb	21	11	mechanism	mechanism	NN
cord-024716-1waejlwb	21	12	behind	behind	IN
cord-024716-1waejlwb	21	13	its	-PRON-	PRP$
cord-024716-1waejlwb	21	14	cross-	cross-	NN
cord-024716-1waejlwb	21	15	protection	protection	NN
cord-024716-1waejlwb	21	16	against	against	IN
cord-024716-1waejlwb	21	17	the	the	DT
cord-024716-1waejlwb	21	18	novel	novel	JJ
cord-024716-1waejlwb	21	19	coronavirus	coronavirus	NN
cord-024716-1waejlwb	21	20	.	.	.
cord-024716-1waejlwb	22	1	Data	datum	NNS
cord-024716-1waejlwb	22	2	on	on	IN
cord-024716-1waejlwb	22	3	the	the	DT
cord-024716-1waejlwb	22	4	"	"	``
cord-024716-1waejlwb	22	5	total	total	JJ
cord-024716-1waejlwb	22	6	number	number	NN
cord-024716-1waejlwb	22	7	of	of	IN
cord-024716-1waejlwb	22	8	COVID-19	covid-19	JJ
cord-024716-1waejlwb	22	9	cases	case	NNS
cord-024716-1waejlwb	22	10	per	per	IN
cord-024716-1waejlwb	22	11	1	1	CD
cord-024716-1waejlwb	22	12	million	million	CD
cord-024716-1waejlwb	22	13	population	population	NN
cord-024716-1waejlwb	22	14	"	"	''
cord-024716-1waejlwb	22	15	and	and	CC
cord-024716-1waejlwb	22	16	"	"	``
cord-024716-1waejlwb	22	17	total	total	JJ
cord-024716-1waejlwb	22	18	number	number	NN
cord-024716-1waejlwb	22	19	of	of	IN
cord-024716-1waejlwb	22	20	COVID-19	covid-19	JJ
cord-024716-1waejlwb	22	21	deaths	death	NNS
cord-024716-1waejlwb	22	22	per	per	IN
cord-024716-1waejlwb	22	23	1	1	CD
cord-024716-1waejlwb	22	24	million	million	CD
cord-024716-1waejlwb	22	25	population	population	NN
cord-024716-1waejlwb	22	26	"	"	''
cord-024716-1waejlwb	22	27	of	of	IN
cord-024716-1waejlwb	22	28	different	different	JJ
cord-024716-1waejlwb	22	29	countries	country	NNS
cord-024716-1waejlwb	22	30	were	be	VBD
cord-024716-1waejlwb	22	31	obtained	obtain	VBN
cord-024716-1waejlwb	22	32	from	from	IN
cord-024716-1waejlwb	22	33	an	an	DT
cord-024716-1waejlwb	22	34	online	online	JJ
cord-024716-1waejlwb	22	35	source	source	NN
cord-024716-1waejlwb	22	36	.	.	.
cord-024716-1waejlwb	23	1	[	[	-LRB-
cord-024716-1waejlwb	23	2	1	1	CD
cord-024716-1waejlwb	23	3	]	]	-RRB-
cord-024716-1waejlwb	23	4	Data	datum	NNS
cord-024716-1waejlwb	23	5	on	on	IN
cord-024716-1waejlwb	23	6	the	the	DT
cord-024716-1waejlwb	23	7	"	"	``
cord-024716-1waejlwb	23	8	BCG	BCG	NNP
cord-024716-1waejlwb	23	9	policy	policy	NN
cord-024716-1waejlwb	23	10	,	,	,
cord-024716-1waejlwb	23	11	"	"	''
cord-024716-1waejlwb	23	12	"	"	``
cord-024716-1waejlwb	23	13	incidence	incidence	NN
cord-024716-1waejlwb	23	14	of	of	IN
cord-024716-1waejlwb	23	15	TB/1,000,000	TB/1,000,000	NNP
cord-024716-1waejlwb	23	16	population	population	NN
cord-024716-1waejlwb	23	17	,	,	,
cord-024716-1waejlwb	23	18	"	"	''
cord-024716-1waejlwb	23	19	and	and	CC
cord-024716-1waejlwb	23	20	the	the	DT
cord-024716-1waejlwb	23	21	"	"	``
cord-024716-1waejlwb	23	22	income	income	NN
cord-024716-1waejlwb	23	23	group	group	NN
cord-024716-1waejlwb	23	24	according	accord	VBG
cord-024716-1waejlwb	23	25	to	to	IN
cord-024716-1waejlwb	23	26	World	World	NNP
cord-024716-1waejlwb	23	27	Bank	Bank	NNP
cord-024716-1waejlwb	23	28	data	datum	NNS
cord-024716-1waejlwb	23	29	"	"	''
cord-024716-1waejlwb	23	30	of	of	IN
cord-024716-1waejlwb	23	31	these	these	DT
cord-024716-1waejlwb	23	32	countries	country	NNS
cord-024716-1waejlwb	23	33	were	be	VBD
cord-024716-1waejlwb	23	34	obtained	obtain	VBN
cord-024716-1waejlwb	23	35	from	from	IN
cord-024716-1waejlwb	23	36	another	another	DT
cord-024716-1waejlwb	23	37	online	online	JJ
cord-024716-1waejlwb	23	38	source	source	NN
cord-024716-1waejlwb	23	39	.	.	.
cord-024716-1waejlwb	24	1	Countries	country	NNS
cord-024716-1waejlwb	24	2	with	with	IN
cord-024716-1waejlwb	24	3	a	a	DT
cord-024716-1waejlwb	24	4	total	total	JJ
cord-024716-1waejlwb	24	5	case	case	NN
cord-024716-1waejlwb	24	6	fatality	fatality	NN
cord-024716-1waejlwb	24	7	20	20	CD
cord-024716-1waejlwb	24	8	(	(	-LRB-
cord-024716-1waejlwb	24	9	on	on	IN
cord-024716-1waejlwb	24	10	the	the	DT
cord-024716-1waejlwb	24	11	date	date	NN
cord-024716-1waejlwb	24	12	of	of	IN
cord-024716-1waejlwb	24	13	the	the	DT
cord-024716-1waejlwb	24	14	study	study	NN
cord-024716-1waejlwb	24	15	)	)	-RRB-
cord-024716-1waejlwb	24	16	were	be	VBD
cord-024716-1waejlwb	24	17	included	include	VBN
cord-024716-1waejlwb	24	18	.	.	.
cord-024716-1waejlwb	25	1	[	[	-LRB-
cord-024716-1waejlwb	25	2	3	3	CD
cord-024716-1waejlwb	25	3	]	]	-RRB-
cord-024716-1waejlwb	26	1	The	the	DT
cord-024716-1waejlwb	26	2	countries	country	NNS
cord-024716-1waejlwb	26	3	were	be	VBD
cord-024716-1waejlwb	26	4	divided	divide	VBN
cord-024716-1waejlwb	26	5	into	into	IN
cord-024716-1waejlwb	26	6	two	two	CD
cord-024716-1waejlwb	26	7	groups	group	NNS
cord-024716-1waejlwb	26	8	:	:	:
cord-024716-1waejlwb	26	9	Group	Group	NNP
cord-024716-1waejlwb	26	10	A	A	NNP
cord-024716-1waejlwb	26	11	containing	contain	VBG
cord-024716-1waejlwb	26	12	the	the	DT
cord-024716-1waejlwb	26	13	countries	country	NNS
cord-024716-1waejlwb	26	14	"	"	''
cord-024716-1waejlwb	26	15	where	where	WRB
cord-024716-1waejlwb	26	16	universal	universal	JJ
cord-024716-1waejlwb	26	17	BCG	BCG	NNP
cord-024716-1waejlwb	26	18	policy	policy	NN
cord-024716-1waejlwb	26	19	is	be	VBZ
cord-024716-1waejlwb	26	20	in	in	IN
cord-024716-1waejlwb	26	21	practice	practice	NN
cord-024716-1waejlwb	26	22	at	at	IN
cord-024716-1waejlwb	26	23	present	present	JJ
cord-024716-1waejlwb	26	24	"	"	''
cord-024716-1waejlwb	26	25	and	and	CC
cord-024716-1waejlwb	26	26	Group	Group	NNP
cord-024716-1waejlwb	26	27	B	B	NNP
cord-024716-1waejlwb	26	28	containing	contain	VBG
cord-024716-1waejlwb	26	29	the	the	DT
cord-024716-1waejlwb	26	30	countries	country	NNS
cord-024716-1waejlwb	26	31	"	"	''
cord-024716-1waejlwb	26	32	where	where	WRB
cord-024716-1waejlwb	26	33	universal	universal	JJ
cord-024716-1waejlwb	26	34	BCG	BCG	NNP
cord-024716-1waejlwb	26	35	policy	policy	NN
cord-024716-1waejlwb	26	36	is	be	VBZ
cord-024716-1waejlwb	26	37	not	not	RB
cord-024716-1waejlwb	26	38	practiced	practice	VBN
cord-024716-1waejlwb	26	39	at	at	IN
cord-024716-1waejlwb	26	40	present	present	NN
cord-024716-1waejlwb	26	41	.	.	.
cord-024716-1waejlwb	27	1	"	"	``
cord-024716-1waejlwb	27	2	We	-PRON-	PRP
cord-024716-1waejlwb	27	3	compared	compare	VBD
cord-024716-1waejlwb	27	4	the	the	DT
cord-024716-1waejlwb	27	5	"	"	``
cord-024716-1waejlwb	27	6	total	total	JJ
cord-024716-1waejlwb	27	7	number	number	NN
cord-024716-1waejlwb	27	8	of	of	IN
cord-024716-1waejlwb	27	9	COVID-19	covid-19	JJ
cord-024716-1waejlwb	27	10	cases	case	NNS
cord-024716-1waejlwb	27	11	per	per	IN
cord-024716-1waejlwb	27	12	1	1	CD
cord-024716-1waejlwb	27	13	million	million	CD
cord-024716-1waejlwb	27	14	population	population	NN
cord-024716-1waejlwb	27	15	"	"	''
cord-024716-1waejlwb	27	16	as	as	RB
cord-024716-1waejlwb	27	17	well	well	RB
cord-024716-1waejlwb	27	18	as	as	IN
cord-024716-1waejlwb	27	19	the	the	DT
cord-024716-1waejlwb	27	20	"	"	``
cord-024716-1waejlwb	27	21	total	total	JJ
cord-024716-1waejlwb	27	22	number	number	NN
cord-024716-1waejlwb	27	23	of	of	IN
cord-024716-1waejlwb	27	24	deaths	death	NNS
cord-024716-1waejlwb	27	25	per	per	IN
cord-024716-1waejlwb	27	26	1	1	CD
cord-024716-1waejlwb	27	27	million	million	CD
cord-024716-1waejlwb	27	28	population	population	NN
cord-024716-1waejlwb	27	29	"	"	''
cord-024716-1waejlwb	27	30	between	between	IN
cord-024716-1waejlwb	27	31	Groups	group	NNS
cord-024716-1waejlwb	27	32	A	A	NNP
cord-024716-1waejlwb	27	33	and	and	CC
cord-024716-1waejlwb	27	34	B	b	NN
cord-024716-1waejlwb	27	35	to	to	TO
cord-024716-1waejlwb	27	36	look	look	VB
cord-024716-1waejlwb	27	37	for	for	IN
cord-024716-1waejlwb	27	38	any	any	DT
cord-024716-1waejlwb	27	39	statistical	statistical	JJ
cord-024716-1waejlwb	27	40	significance	significance	NN
cord-024716-1waejlwb	27	41	.	.	.
cord-024716-1waejlwb	28	1	Subsequently	subsequently	RB
cord-024716-1waejlwb	28	2	,	,	,
cord-024716-1waejlwb	28	3	we	-PRON-	PRP
cord-024716-1waejlwb	28	4	divided	divide	VBD
cord-024716-1waejlwb	28	5	the	the	DT
cord-024716-1waejlwb	28	6	countries	country	NNS
cord-024716-1waejlwb	28	7	with	with	IN
cord-024716-1waejlwb	28	8	"	"	``
cord-024716-1waejlwb	28	9	no	no	DT
cord-024716-1waejlwb	28	10	universal	universal	JJ
cord-024716-1waejlwb	28	11	BCG	BCG	NNP
cord-024716-1waejlwb	28	12	policy	policy	NN
cord-024716-1waejlwb	28	13	"	"	''
cord-024716-1waejlwb	28	14	into	into	IN
cord-024716-1waejlwb	28	15	two	two	CD
cord-024716-1waejlwb	28	16	groups	group	NNS
cord-024716-1waejlwb	28	17	:	:	:
cord-024716-1waejlwb	29	1	Group	Group	NNP
cord-024716-1waejlwb	29	2	C	C	NNP
cord-024716-1waejlwb	29	3	containing	contain	VBG
cord-024716-1waejlwb	29	4	the	the	DT
cord-024716-1waejlwb	29	5	countries	country	NNS
cord-024716-1waejlwb	29	6	where	where	WRB
cord-024716-1waejlwb	29	7	"	"	``
cord-024716-1waejlwb	29	8	universal	universal	JJ
cord-024716-1waejlwb	29	9	BCG	BCG	NNP
cord-024716-1waejlwb	29	10	policy	policy	NN
cord-024716-1waejlwb	29	11	was	be	VBD
cord-024716-1waejlwb	29	12	previously	previously	RB
cord-024716-1waejlwb	29	13	present	present	JJ
cord-024716-1waejlwb	29	14	,	,	,
cord-024716-1waejlwb	29	15	but	but	CC
cord-024716-1waejlwb	29	16	has	have	VBZ
cord-024716-1waejlwb	29	17	now	now	RB
cord-024716-1waejlwb	29	18	been	be	VBN
cord-024716-1waejlwb	29	19	stopped	stop	VBN
cord-024716-1waejlwb	29	20	"	"	''
cord-024716-1waejlwb	29	21	and	and	CC
cord-024716-1waejlwb	29	22	Group	Group	NNP
cord-024716-1waejlwb	29	23	D	D	NNP
cord-024716-1waejlwb	29	24	containing	contain	VBG
cord-024716-1waejlwb	29	25	the	the	DT
cord-024716-1waejlwb	29	26	countries	country	NNS
cord-024716-1waejlwb	29	27	where	where	WRB
cord-024716-1waejlwb	29	28	"	"	``
cord-024716-1waejlwb	29	29	universal	universal	JJ
cord-024716-1waejlwb	29	30	BCG	BCG	NNP
cord-024716-1waejlwb	29	31	policy	policy	NN
cord-024716-1waejlwb	29	32	was	be	VBD
cord-024716-1waejlwb	29	33	never	never	RB
cord-024716-1waejlwb	29	34	present	present	JJ
cord-024716-1waejlwb	29	35	.	.	.
cord-024716-1waejlwb	30	1	"	"	''
cord-024716-1waejlwb	31	1	The	the	DT
cord-024716-1waejlwb	31	2	number	number	NN
cord-024716-1waejlwb	31	3	of	of	IN
cord-024716-1waejlwb	31	4	COVID-19	covid-19	JJ
cord-024716-1waejlwb	31	5	cases	case	NNS
cord-024716-1waejlwb	31	6	per	per	IN
cord-024716-1waejlwb	31	7	1	1	CD
cord-024716-1waejlwb	31	8	million	million	CD
cord-024716-1waejlwb	31	9	population	population	NN
cord-024716-1waejlwb	31	10	in	in	IN
cord-024716-1waejlwb	31	11	Group	Group	NNP
cord-024716-1waejlwb	31	12	C	C	NNP
cord-024716-1waejlwb	31	13	and	and	CC
cord-024716-1waejlwb	31	14	Group	Group	NNP
cord-024716-1waejlwb	31	15	D	D	NNP
cord-024716-1waejlwb	31	16	was	be	VBD
cord-024716-1waejlwb	31	17	compared	compare	VBN
cord-024716-1waejlwb	31	18	to	to	TO
cord-024716-1waejlwb	31	19	look	look	VB
cord-024716-1waejlwb	31	20	for	for	IN
cord-024716-1waejlwb	31	21	any	any	DT
cord-024716-1waejlwb	31	22	statistically	statistically	RB
cord-024716-1waejlwb	31	23	significant	significant	JJ
cord-024716-1waejlwb	31	24	difference	difference	NN
cord-024716-1waejlwb	31	25	.	.	.
cord-024716-1waejlwb	32	1	Similarly	similarly	RB
cord-024716-1waejlwb	32	2	,	,	,
cord-024716-1waejlwb	32	3	the	the	DT
cord-024716-1waejlwb	32	4	number	number	NN
cord-024716-1waejlwb	32	5	of	of	IN
cord-024716-1waejlwb	32	6	deaths	death	NNS
cord-024716-1waejlwb	32	7	per	per	IN
cord-024716-1waejlwb	32	8	million	million	CD
cord-024716-1waejlwb	32	9	was	be	VBD
cord-024716-1waejlwb	32	10	also	also	RB
cord-024716-1waejlwb	32	11	compared	compare	VBN
cord-024716-1waejlwb	32	12	between	between	IN
cord-024716-1waejlwb	32	13	Groups	group	NNS
cord-024716-1waejlwb	32	14	C	C	NNP
cord-024716-1waejlwb	32	15	and	and	CC
cord-024716-1waejlwb	32	16	D.	D.	NNP
cord-024716-1waejlwb	33	1	Eventually	eventually	RB
cord-024716-1waejlwb	33	2	,	,	,
cord-024716-1waejlwb	33	3	we	-PRON-	PRP
cord-024716-1waejlwb	33	4	grouped	group	VBD
cord-024716-1waejlwb	33	5	all	all	PDT
cord-024716-1waejlwb	33	6	the	the	DT
cord-024716-1waejlwb	33	7	countries	country	NNS
cord-024716-1waejlwb	33	8	into	into	IN
cord-024716-1waejlwb	33	9	two	two	CD
cord-024716-1waejlwb	33	10	groups	group	NNS
cord-024716-1waejlwb	33	11	:	:	:
cord-024716-1waejlwb	34	1	The	the	DT
cord-024716-1waejlwb	34	2	first	first	JJ
cord-024716-1waejlwb	34	3	group	group	NN
cord-024716-1waejlwb	34	4	(	(	-LRB-
cord-024716-1waejlwb	34	5	Group	Group	NNP
cord-024716-1waejlwb	34	6	E	E	NNP
cord-024716-1waejlwb	34	7	)	)	-RRB-
cord-024716-1waejlwb	34	8	comprising	comprise	VBG
cord-024716-1waejlwb	34	9	"	"	``
cord-024716-1waejlwb	34	10	countries	country	NNS
cord-024716-1waejlwb	34	11	where	where	WRB
cord-024716-1waejlwb	34	12	incidence	incidence	NN
cord-024716-1waejlwb	34	13	of	of	IN
cord-024716-1waejlwb	34	14	tuberculosis	tuberculosis	NN
cord-024716-1waejlwb	34	15	is	be	VBZ
cord-024716-1waejlwb	34	16	≤20/1,000,000	≤20/1,000,000	NNP
cord-024716-1waejlwb	34	17	,	,	,
cord-024716-1waejlwb	34	18	"	"	''
cord-024716-1waejlwb	34	19	i.e.	i.e.	FW
cord-024716-1waejlwb	34	20	,	,	,
cord-024716-1waejlwb	34	21	countries	country	NNS
cord-024716-1waejlwb	34	22	with	with	IN
cord-024716-1waejlwb	34	23	low	low	JJ
cord-024716-1waejlwb	34	24	incidence	incidence	NN
cord-024716-1waejlwb	34	25	of	of	IN
cord-024716-1waejlwb	34	26	tuberculosis	tuberculosis	NN
cord-024716-1waejlwb	34	27	and	and	CC
cord-024716-1waejlwb	34	28	the	the	DT
cord-024716-1waejlwb	34	29	second	second	JJ
cord-024716-1waejlwb	34	30	group	group	NN
cord-024716-1waejlwb	34	31	(	(	-LRB-
cord-024716-1waejlwb	34	32	Group	Group	NNP
cord-024716-1waejlwb	34	33	F	F	NNP
cord-024716-1waejlwb	34	34	)	)	-RRB-
cord-024716-1waejlwb	34	35	comprising	comprise	VBG
cord-024716-1waejlwb	34	36	nations	nation	NNS
cord-024716-1waejlwb	34	37	"	"	''
cord-024716-1waejlwb	34	38	where	where	WRB
cord-024716-1waejlwb	34	39	the	the	DT
cord-024716-1waejlwb	34	40	incidence	incidence	NN
cord-024716-1waejlwb	34	41	of	of	IN
cord-024716-1waejlwb	34	42	tuberculosis	tuberculosis	NN
cord-024716-1waejlwb	34	43	is	be	VBZ
cord-024716-1waejlwb	34	44	>	>	XX
cord-024716-1waejlwb	34	45	20/1,000,000	20/1,000,000	CD
cord-024716-1waejlwb	34	46	,	,	,
cord-024716-1waejlwb	34	47	"	"	''
cord-024716-1waejlwb	34	48	i.e.	i.e.	FW
cord-024716-1waejlwb	34	49	countries	country	NNS
cord-024716-1waejlwb	34	50	with	with	IN
cord-024716-1waejlwb	34	51	higher	high	JJR
cord-024716-1waejlwb	34	52	incidence	incidence	NN
cord-024716-1waejlwb	34	53	of	of	IN
cord-024716-1waejlwb	34	54	tuberculosis	tuberculosis	NN
cord-024716-1waejlwb	34	55	)	)	-RRB-
cord-024716-1waejlwb	34	56	.	.	.
cord-024716-1waejlwb	35	1	We	-PRON-	PRP
cord-024716-1waejlwb	35	2	compared	compare	VBD
cord-024716-1waejlwb	35	3	the	the	DT
cord-024716-1waejlwb	35	4	"	"	``
cord-024716-1waejlwb	35	5	total	total	JJ
cord-024716-1waejlwb	35	6	number	number	NN
cord-024716-1waejlwb	35	7	of	of	IN
cord-024716-1waejlwb	35	8	COVID-19	covid-19	JJ
cord-024716-1waejlwb	35	9	cases	case	NNS
cord-024716-1waejlwb	35	10	per	per	IN
cord-024716-1waejlwb	35	11	1	1	CD
cord-024716-1waejlwb	35	12	million	million	CD
cord-024716-1waejlwb	35	13	population	population	NN
cord-024716-1waejlwb	35	14	"	"	''
cord-024716-1waejlwb	35	15	as	as	RB
cord-024716-1waejlwb	35	16	well	well	RB
cord-024716-1waejlwb	35	17	as	as	IN
cord-024716-1waejlwb	35	18	the	the	DT
cord-024716-1waejlwb	35	19	"	"	``
cord-024716-1waejlwb	35	20	total	total	JJ
cord-024716-1waejlwb	35	21	number	number	NN
cord-024716-1waejlwb	35	22	of	of	IN
cord-024716-1waejlwb	35	23	deaths	death	NNS
cord-024716-1waejlwb	35	24	per	per	IN
cord-024716-1waejlwb	35	25	1	1	CD
cord-024716-1waejlwb	35	26	million	million	CD
cord-024716-1waejlwb	35	27	population	population	NN
cord-024716-1waejlwb	35	28	"	"	''
cord-024716-1waejlwb	35	29	between	between	IN
cord-024716-1waejlwb	35	30	Groups	group	NNS
cord-024716-1waejlwb	35	31	E	E	NNP
cord-024716-1waejlwb	35	32	and	and	CC
cord-024716-1waejlwb	36	1	F.	F.	NNP
cord-024716-1waejlwb	36	2	The	the	DT
cord-024716-1waejlwb	36	3	data	datum	NNS
cord-024716-1waejlwb	36	4	in	in	IN
cord-024716-1waejlwb	36	5	the	the	DT
cord-024716-1waejlwb	36	6	two	two	CD
cord-024716-1waejlwb	36	7	groups	group	NNS
cord-024716-1waejlwb	36	8	were	be	VBD
cord-024716-1waejlwb	36	9	tested	test	VBN
cord-024716-1waejlwb	36	10	for	for	IN
cord-024716-1waejlwb	36	11	statistical	statistical	JJ
cord-024716-1waejlwb	36	12	significance	significance	NN
cord-024716-1waejlwb	36	13	using	use	VBG
cord-024716-1waejlwb	36	14	the	the	DT
cord-024716-1waejlwb	36	15	Mann	Mann	NNP
cord-024716-1waejlwb	36	16	-	-	HYPH
cord-024716-1waejlwb	36	17	Whitney	Whitney	NNP
cord-024716-1waejlwb	36	18	U	U	NNP
cord-024716-1waejlwb	36	19	-	-	HYPH
cord-024716-1waejlwb	36	20	test	test	NN
cord-024716-1waejlwb	36	21	.	.	.
cord-024716-1waejlwb	37	1	An	an	DT
cord-024716-1waejlwb	37	2	online	online	JJ
cord-024716-1waejlwb	37	3	software	software	NN
cord-024716-1waejlwb	37	4	was	be	VBD
cord-024716-1waejlwb	37	5	used	use	VBN
cord-024716-1waejlwb	37	6	to	to	TO
cord-024716-1waejlwb	37	7	analyze	analyze	VB
cord-024716-1waejlwb	37	8	the	the	DT
cord-024716-1waejlwb	37	9	data	datum	NNS
cord-024716-1waejlwb	37	10	available	available	JJ
cord-024716-1waejlwb	37	11	at	at	IN
cord-024716-1waejlwb	37	12	http://www	http://www	NNP
cord-024716-1waejlwb	37	13	.	.	.
cord-024716-1waejlwb	38	1	statskingdom.com/170median_mann_whitney.html	statskingdom.com/170median_mann_whitney.html	NNP
cord-024716-1waejlwb	38	2	.	.	.
cord-024716-1waejlwb	39	1	At	at	IN
cord-024716-1waejlwb	39	2	the	the	DT
cord-024716-1waejlwb	39	3	time	time	NN
cord-024716-1waejlwb	39	4	of	of	IN
cord-024716-1waejlwb	39	5	the	the	DT
cord-024716-1waejlwb	39	6	study	study	NN
cord-024716-1waejlwb	39	7	,	,	,
cord-024716-1waejlwb	39	8	50	50	CD
cord-024716-1waejlwb	39	9	countries	country	NNS
cord-024716-1waejlwb	39	10	had	have	VBD
cord-024716-1waejlwb	39	11	a	a	DT
cord-024716-1waejlwb	39	12	total	total	JJ
cord-024716-1waejlwb	39	13	COVID-19	covid-19	JJ
cord-024716-1waejlwb	39	14	deaths	death	NNS
cord-024716-1waejlwb	39	15	of	of	IN
cord-024716-1waejlwb	39	16	≥20	≥20	NNP
cord-024716-1waejlwb	39	17	.	.	.
cord-024716-1waejlwb	40	1	Out	out	IN
cord-024716-1waejlwb	40	2	of	of	IN
cord-024716-1waejlwb	40	3	these	these	DT
cord-024716-1waejlwb	40	4	,	,	,
cord-024716-1waejlwb	40	5	21	21	CD
cord-024716-1waejlwb	40	6	countries	country	NNS
cord-024716-1waejlwb	40	7	do	do	VBP
cord-024716-1waejlwb	40	8	not	not	RB
cord-024716-1waejlwb	40	9	have	have	VB
cord-024716-1waejlwb	40	10	a	a	DT
cord-024716-1waejlwb	40	11	universal	universal	JJ
cord-024716-1waejlwb	40	12	BCG	BCG	NNP
cord-024716-1waejlwb	40	13	vaccination	vaccination	NN
cord-024716-1waejlwb	40	14	policy	policy	NN
cord-024716-1waejlwb	40	15	at	at	IN
cord-024716-1waejlwb	40	16	present	present	NN
cord-024716-1waejlwb	40	17	,	,	,
cord-024716-1waejlwb	40	18	whereas	whereas	IN
cord-024716-1waejlwb	40	19	29	29	CD
cord-024716-1waejlwb	40	20	countries	country	NNS
cord-024716-1waejlwb	40	21	have	have	VBP
cord-024716-1waejlwb	40	22	it	-PRON-	PRP
cord-024716-1waejlwb	40	23	.	.	.
cord-024716-1waejlwb	41	1	Out	out	IN
cord-024716-1waejlwb	41	2	of	of	IN
cord-024716-1waejlwb	41	3	the	the	DT
cord-024716-1waejlwb	41	4	21	21	CD
cord-024716-1waejlwb	41	5	countries	country	NNS
cord-024716-1waejlwb	41	6	with	with	IN
cord-024716-1waejlwb	41	7	no	no	DT
cord-024716-1waejlwb	41	8	universal	universal	JJ
cord-024716-1waejlwb	41	9	BCG	BCG	NNP
cord-024716-1waejlwb	41	10	policy	policy	NN
cord-024716-1waejlwb	41	11	,	,	,
cord-024716-1waejlwb	41	12	20	20	CD
cord-024716-1waejlwb	41	13	countries	country	NNS
cord-024716-1waejlwb	41	14	are	be	VBP
cord-024716-1waejlwb	41	15	from	from	IN
cord-024716-1waejlwb	41	16	high	high	JJ
cord-024716-1waejlwb	41	17	-	-	HYPH
cord-024716-1waejlwb	41	18	income	income	NN
cord-024716-1waejlwb	41	19	group	group	NN
cord-024716-1waejlwb	41	20	and	and	CC
cord-024716-1waejlwb	41	21	one	one	CD
cord-024716-1waejlwb	41	22	country	country	NN
cord-024716-1waejlwb	41	23	is	be	VBZ
cord-024716-1waejlwb	41	24	from	from	IN
cord-024716-1waejlwb	41	25	upper	upper	JJ
cord-024716-1waejlwb	41	26	middle	middle	JJ
cord-024716-1waejlwb	41	27	-	-	HYPH
cord-024716-1waejlwb	41	28	income	income	NN
cord-024716-1waejlwb	41	29	group	group	NN
cord-024716-1waejlwb	41	30	.	.	.
cord-024716-1waejlwb	42	1	Out	out	IN
cord-024716-1waejlwb	42	2	of	of	IN
cord-024716-1waejlwb	42	3	the	the	DT
cord-024716-1waejlwb	42	4	29	29	CD
cord-024716-1waejlwb	42	5	countries	country	NNS
cord-024716-1waejlwb	42	6	with	with	IN
cord-024716-1waejlwb	42	7	universal	universal	JJ
cord-024716-1waejlwb	42	8	BCG	BCG	NNP
cord-024716-1waejlwb	42	9	vaccination	vaccination	NN
cord-024716-1waejlwb	42	10	,	,	,
cord-024716-1waejlwb	42	11	7	7	CD
cord-024716-1waejlwb	42	12	are	be	VBP
cord-024716-1waejlwb	42	13	from	from	IN
cord-024716-1waejlwb	42	14	high	high	JJ
cord-024716-1waejlwb	42	15	income	income	NN
cord-024716-1waejlwb	42	16	,	,	,
cord-024716-1waejlwb	42	17	15	15	CD
cord-024716-1waejlwb	42	18	are	be	VBP
cord-024716-1waejlwb	42	19	from	from	IN
cord-024716-1waejlwb	42	20	upper	upper	JJ
cord-024716-1waejlwb	42	21	middle	middle	NN
cord-024716-1waejlwb	42	22	,	,	,
cord-024716-1waejlwb	42	23	and	and	CC
cord-024716-1waejlwb	42	24	7	7	CD
cord-024716-1waejlwb	42	25	are	be	VBP
cord-024716-1waejlwb	42	26	from	from	IN
cord-024716-1waejlwb	42	27	lower	low	JJR
cord-024716-1waejlwb	42	28	middle	middle	JJ
cord-024716-1waejlwb	42	29	-	-	HYPH
cord-024716-1waejlwb	42	30	income	income	NN
cord-024716-1waejlwb	42	31	group	group	NN
cord-024716-1waejlwb	42	32	.	.	.
cord-024716-1waejlwb	43	1	The	the	DT
cord-024716-1waejlwb	43	2	countries	country	NNS
cord-024716-1waejlwb	43	3	where	where	WRB
cord-024716-1waejlwb	43	4	universal	universal	JJ
cord-024716-1waejlwb	43	5	BCG	BCG	NNP
cord-024716-1waejlwb	43	6	vaccination	vaccination	NN
cord-024716-1waejlwb	43	7	is	be	VBZ
cord-024716-1waejlwb	43	8	not	not	RB
cord-024716-1waejlwb	43	9	practiced	practice	VBN
cord-024716-1waejlwb	43	10	have	have	VB
cord-024716-1waejlwb	43	11	a	a	DT
cord-024716-1waejlwb	43	12	mean	mean	JJ
cord-024716-1waejlwb	43	13	COVID-19	covid-19	JJ
cord-024716-1waejlwb	43	14	positive	positive	JJ
cord-024716-1waejlwb	43	15	cases	case	NNS
cord-024716-1waejlwb	43	16	of	of	IN
cord-024716-1waejlwb	43	17	1272.9	1272.9	CD
cord-024716-1waejlwb	43	18	(	(	-LRB-
cord-024716-1waejlwb	43	19	standard	standard	JJ
cord-024716-1waejlwb	43	20	deviation	deviation	NN
cord-024716-1waejlwb	43	21	1557.9	1557.9	CD
cord-024716-1waejlwb	43	22	)	)	-RRB-
cord-024716-1waejlwb	43	23	per	per	IN
cord-024716-1waejlwb	43	24	1	1	CD
cord-024716-1waejlwb	43	25	million	million	CD
cord-024716-1waejlwb	43	26	population	population	NN
cord-024716-1waejlwb	43	27	with	with	IN
cord-024716-1waejlwb	43	28	a	a	DT
cord-024716-1waejlwb	43	29	median	median	NN
cord-024716-1waejlwb	43	30	of	of	IN
cord-024716-1waejlwb	43	31	795	795	CD
cord-024716-1waejlwb	43	32	.	.	.
cord-024716-1waejlwb	44	1	The	the	DT
cord-024716-1waejlwb	44	2	countries	country	NNS
cord-024716-1waejlwb	44	3	where	where	WRB
cord-024716-1waejlwb	44	4	universal	universal	JJ
cord-024716-1waejlwb	44	5	BCG	BCG	NNP
cord-024716-1waejlwb	44	6	vaccination	vaccination	NN
cord-024716-1waejlwb	44	7	is	be	VBZ
cord-024716-1waejlwb	44	8	practiced	practice	VBN
cord-024716-1waejlwb	44	9	have	have	VBP
cord-024716-1waejlwb	44	10	a	a	DT
cord-024716-1waejlwb	44	11	mean	mean	JJ
cord-024716-1waejlwb	44	12	COVID-19	covid-19	JJ
cord-024716-1waejlwb	44	13	positive	positive	JJ
cord-024716-1waejlwb	44	14	cases	case	NNS
cord-024716-1waejlwb	44	15	of	of	IN
cord-024716-1waejlwb	44	16	131.1	131.1	CD
cord-024716-1waejlwb	44	17	(	(	-LRB-
cord-024716-1waejlwb	44	18	standard	standard	JJ
cord-024716-1waejlwb	44	19	deviation	deviation	NN
cord-024716-1waejlwb	44	20	208.7	208.7	CD
cord-024716-1waejlwb	44	21	)	)	-RRB-
cord-024716-1waejlwb	44	22	per	per	IN
cord-024716-1waejlwb	44	23	1	1	CD
cord-024716-1waejlwb	44	24	million	million	CD
cord-024716-1waejlwb	44	25	population	population	NN
cord-024716-1waejlwb	44	26	with	with	IN
cord-024716-1waejlwb	44	27	a	a	DT
cord-024716-1waejlwb	44	28	median	median	NN
cord-024716-1waejlwb	44	29	of	of	IN
cord-024716-1waejlwb	44	30	40	40	CD
cord-024716-1waejlwb	44	31	.	.	.
cord-024716-1waejlwb	45	1	The	the	DT
cord-024716-1waejlwb	45	2	difference	difference	NN
cord-024716-1waejlwb	45	3	is	be	VBZ
cord-024716-1waejlwb	45	4	statistically	statistically	RB
cord-024716-1waejlwb	45	5	significant	significant	JJ
cord-024716-1waejlwb	45	6	(	(	-LRB-
cord-024716-1waejlwb	45	7	P	p	NN
cord-024716-1waejlwb	45	8	<	<	XX
cord-024716-1waejlwb	45	9	0.001	0.001	CD
cord-024716-1waejlwb	45	10	)	)	-RRB-
cord-024716-1waejlwb	46	1	[	[	-LRB-
cord-024716-1waejlwb	46	2	Figure	figure	NN
cord-024716-1waejlwb	46	3	1a	1a	CD
cord-024716-1waejlwb	46	4	]	]	-RRB-
cord-024716-1waejlwb	46	5	.	.	.
cord-024716-1waejlwb	47	1	The	the	DT
cord-024716-1waejlwb	47	2	countries	country	NNS
cord-024716-1waejlwb	47	3	where	where	WRB
cord-024716-1waejlwb	47	4	universal	universal	JJ
cord-024716-1waejlwb	47	5	BCG	BCG	NNP
cord-024716-1waejlwb	47	6	vaccination	vaccination	NN
cord-024716-1waejlwb	47	7	is	be	VBZ
cord-024716-1waejlwb	47	8	not	not	RB
cord-024716-1waejlwb	47	9	practiced	practice	VBN
cord-024716-1waejlwb	47	10	have	have	VB
cord-024716-1waejlwb	48	1	a	a	DT
cord-024716-1waejlwb	48	2	mean	mean	JJ
cord-024716-1waejlwb	48	3	COVID-19	covid-19	JJ
cord-024716-1waejlwb	48	4	deaths	death	NNS
cord-024716-1waejlwb	48	5	of	of	IN
cord-024716-1waejlwb	48	6	80.7	80.7	CD
cord-024716-1waejlwb	48	7	(	(	-LRB-
cord-024716-1waejlwb	48	8	standard	standard	JJ
cord-024716-1waejlwb	48	9	deviation	deviation	NN
cord-024716-1waejlwb	48	10	180.8	180.8	CD
cord-024716-1waejlwb	48	11	)	)	-RRB-
cord-024716-1waejlwb	48	12	per	per	IN
cord-024716-1waejlwb	48	13	1	1	CD
cord-024716-1waejlwb	48	14	million	million	CD
cord-024716-1waejlwb	48	15	population	population	NN
cord-024716-1waejlwb	48	16	with	with	IN
cord-024716-1waejlwb	48	17	a	a	DT
cord-024716-1waejlwb	48	18	median	median	NN
cord-024716-1waejlwb	48	19	of	of	IN
cord-024716-1waejlwb	48	20	18	18	CD
cord-024716-1waejlwb	48	21	.	.	.
cord-024716-1waejlwb	49	1	The	the	DT
cord-024716-1waejlwb	49	2	countries	country	NNS
cord-024716-1waejlwb	49	3	where	where	WRB
cord-024716-1waejlwb	49	4	universal	universal	JJ
cord-024716-1waejlwb	49	5	BCG	BCG	NNP
cord-024716-1waejlwb	49	6	vaccination	vaccination	NN
cord-024716-1waejlwb	49	7	is	be	VBZ
cord-024716-1waejlwb	49	8	practiced	practice	VBN
cord-024716-1waejlwb	49	9	have	have	VBP
cord-024716-1waejlwb	49	10	a	a	DT
cord-024716-1waejlwb	49	11	mean	mean	JJ
cord-024716-1waejlwb	49	12	COVID-19	covid-19	JJ
cord-024716-1waejlwb	49	13	positive	positive	JJ
cord-024716-1waejlwb	49	14	deaths	death	NNS
cord-024716-1waejlwb	49	15	of	of	IN
cord-024716-1waejlwb	49	16	4	4	CD
cord-024716-1waejlwb	49	17	(	(	-LRB-
cord-024716-1waejlwb	49	18	standard	standard	JJ
cord-024716-1waejlwb	49	19	deviation	deviation	NN
cord-024716-1waejlwb	49	20	7.6	7.6	CD
cord-024716-1waejlwb	49	21	)	)	-RRB-
cord-024716-1waejlwb	49	22	per	per	IN
cord-024716-1waejlwb	49	23	1	1	CD
cord-024716-1waejlwb	49	24	million	million	CD
cord-024716-1waejlwb	49	25	population	population	NN
cord-024716-1waejlwb	49	26	with	with	IN
cord-024716-1waejlwb	49	27	a	a	DT
cord-024716-1waejlwb	49	28	median	median	NN
cord-024716-1waejlwb	49	29	of	of	IN
cord-024716-1waejlwb	49	30	1	1	CD
cord-024716-1waejlwb	49	31	.	.	.
cord-024716-1waejlwb	50	1	The	the	DT
cord-024716-1waejlwb	50	2	difference	difference	NN
cord-024716-1waejlwb	50	3	is	be	VBZ
cord-024716-1waejlwb	50	4	statistically	statistically	RB
cord-024716-1waejlwb	50	5	significant	significant	JJ
cord-024716-1waejlwb	50	6	(	(	-LRB-
cord-024716-1waejlwb	50	7	P	p	NN
cord-024716-1waejlwb	50	8	<	<	XX
cord-024716-1waejlwb	50	9	0.001	0.001	CD
cord-024716-1waejlwb	50	10	)	)	-RRB-
cord-024716-1waejlwb	51	1	[	[	-LRB-
cord-024716-1waejlwb	51	2	Figure	figure	NN
cord-024716-1waejlwb	51	3	1b	1b	CD
cord-024716-1waejlwb	51	4	]	]	-RRB-
cord-024716-1waejlwb	51	5	.	.	.
cord-024716-1waejlwb	52	1	Out	out	IN
cord-024716-1waejlwb	52	2	of	of	IN
cord-024716-1waejlwb	52	3	the	the	DT
cord-024716-1waejlwb	52	4	21	21	CD
cord-024716-1waejlwb	52	5	countries	country	NNS
cord-024716-1waejlwb	52	6	with	with	IN
cord-024716-1waejlwb	52	7	no	no	DT
cord-024716-1waejlwb	52	8	universal	universal	JJ
cord-024716-1waejlwb	52	9	BCG	BCG	NNP
cord-024716-1waejlwb	52	10	vaccinations	vaccination	NNS
cord-024716-1waejlwb	52	11	policy	policy	NN
cord-024716-1waejlwb	52	12	,	,	,
cord-024716-1waejlwb	52	13	15	15	CD
cord-024716-1waejlwb	52	14	countries	country	NNS
cord-024716-1waejlwb	52	15	had	have	VBD
cord-024716-1waejlwb	52	16	universal	universal	JJ
cord-024716-1waejlwb	52	17	BCG	BCG	NNP
cord-024716-1waejlwb	52	18	vaccination	vaccination	NN
cord-024716-1waejlwb	52	19	policy	policy	NN
cord-024716-1waejlwb	52	20	in	in	IN
cord-024716-1waejlwb	52	21	the	the	DT
cord-024716-1waejlwb	52	22	past	past	NN
cord-024716-1waejlwb	52	23	but	but	CC
cord-024716-1waejlwb	52	24	have	have	VBP
cord-024716-1waejlwb	52	25	stopped	stop	VBN
cord-024716-1waejlwb	52	26	the	the	DT
cord-024716-1waejlwb	52	27	practice	practice	NN
cord-024716-1waejlwb	52	28	at	at	IN
cord-024716-1waejlwb	52	29	present	present	NN
cord-024716-1waejlwb	52	30	(	(	-LRB-
cord-024716-1waejlwb	52	31	Group	Group	NNP
cord-024716-1waejlwb	52	32	C	C	NNP
cord-024716-1waejlwb	52	33	)	)	-RRB-
cord-024716-1waejlwb	52	34	;	;	:
cord-024716-1waejlwb	52	35	five	five	CD
cord-024716-1waejlwb	52	36	countries	country	NNS
cord-024716-1waejlwb	52	37	never	never	RB
cord-024716-1waejlwb	52	38	had	have	VBD
cord-024716-1waejlwb	52	39	universal	universal	JJ
cord-024716-1waejlwb	52	40	BCG	BCG	NNP
cord-024716-1waejlwb	52	41	(	(	-LRB-
cord-024716-1waejlwb	52	42	Group	Group	NNP
cord-024716-1waejlwb	52	43	D	D	NNP
cord-024716-1waejlwb	52	44	)	)	-RRB-
cord-024716-1waejlwb	52	45	and	and	CC
cord-024716-1waejlwb	52	46	data	datum	NNS
cord-024716-1waejlwb	52	47	were	be	VBD
cord-024716-1waejlwb	52	48	not	not	RB
cord-024716-1waejlwb	52	49	available	available	JJ
cord-024716-1waejlwb	52	50	about	about	IN
cord-024716-1waejlwb	52	51	one	one	CD
cord-024716-1waejlwb	52	52	country	country	NN
cord-024716-1waejlwb	52	53	(	(	-LRB-
cord-024716-1waejlwb	52	54	San	San	NNP
cord-024716-1waejlwb	52	55	Marino	Marino	NNP
cord-024716-1waejlwb	52	56	)	)	-RRB-
cord-024716-1waejlwb	52	57	.	.	.
cord-024716-1waejlwb	53	1	The	the	DT
cord-024716-1waejlwb	53	2	difference	difference	NN
cord-024716-1waejlwb	53	3	in	in	IN
cord-024716-1waejlwb	53	4	the	the	DT
cord-024716-1waejlwb	53	5	"	"	``
cord-024716-1waejlwb	53	6	number	number	NN
cord-024716-1waejlwb	53	7	of	of	IN
cord-024716-1waejlwb	53	8	cases	case	NNS
cord-024716-1waejlwb	53	9	per	per	IN
cord-024716-1waejlwb	53	10	1	1	CD
cord-024716-1waejlwb	53	11	million	million	CD
cord-024716-1waejlwb	53	12	"	"	''
cord-024716-1waejlwb	53	13	between	between	IN
cord-024716-1waejlwb	53	14	Group	Group	NNP
cord-024716-1waejlwb	53	15	C	C	NNP
cord-024716-1waejlwb	53	16	and	and	CC
cord-024716-1waejlwb	53	17	Group	Group	NNP
cord-024716-1waejlwb	53	18	D	D	NNP
cord-024716-1waejlwb	53	19	was	be	VBD
cord-024716-1waejlwb	53	20	not	not	RB
cord-024716-1waejlwb	53	21	statistically	statistically	RB
cord-024716-1waejlwb	53	22	significant	significant	JJ
cord-024716-1waejlwb	54	1	(	(	-LRB-
cord-024716-1waejlwb	54	2	P	p	NN
cord-024716-1waejlwb	54	3	=	=	SYM
cord-024716-1waejlwb	54	4	0.8	0.8	CD
cord-024716-1waejlwb	54	5	)	)	-RRB-
cord-024716-1waejlwb	54	6	.	.	.
cord-024716-1waejlwb	55	1	Similarly	similarly	RB
cord-024716-1waejlwb	55	2	,	,	,
cord-024716-1waejlwb	55	3	the	the	DT
cord-024716-1waejlwb	55	4	difference	difference	NN
cord-024716-1waejlwb	55	5	in	in	IN
cord-024716-1waejlwb	55	6	the	the	DT
cord-024716-1waejlwb	55	7	"	"	``
cord-024716-1waejlwb	55	8	number	number	NN
cord-024716-1waejlwb	55	9	of	of	IN
cord-024716-1waejlwb	55	10	deaths	death	NNS
cord-024716-1waejlwb	55	11	per	per	IN
cord-024716-1waejlwb	55	12	1	1	CD
cord-024716-1waejlwb	55	13	million	million	CD
cord-024716-1waejlwb	55	14	"	"	``
cord-024716-1waejlwb	55	15	between	between	IN
cord-024716-1waejlwb	55	16	Groups	group	NNS
cord-024716-1waejlwb	55	17	C	C	NNP
cord-024716-1waejlwb	55	18	and	and	CC
cord-024716-1waejlwb	55	19	D	D	NNP
cord-024716-1waejlwb	55	20	was	be	VBD
cord-024716-1waejlwb	55	21	also	also	RB
cord-024716-1waejlwb	55	22	not	not	RB
cord-024716-1waejlwb	55	23	statistically	statistically	RB
cord-024716-1waejlwb	55	24	significant	significant	JJ
cord-024716-1waejlwb	56	1	(	(	-LRB-
cord-024716-1waejlwb	56	2	P	p	NN
cord-024716-1waejlwb	56	3	=	=	SYM
cord-024716-1waejlwb	56	4	0.2	0.2	CD
cord-024716-1waejlwb	56	5	)	)	-RRB-
cord-024716-1waejlwb	56	6	.	.	.
cord-024716-1waejlwb	57	1	Out	out	IN
cord-024716-1waejlwb	57	2	of	of	IN
cord-024716-1waejlwb	57	3	the	the	DT
cord-024716-1waejlwb	57	4	50	50	CD
cord-024716-1waejlwb	57	5	countries	country	NNS
cord-024716-1waejlwb	57	6	included	include	VBN
cord-024716-1waejlwb	57	7	in	in	IN
cord-024716-1waejlwb	57	8	the	the	DT
cord-024716-1waejlwb	57	9	study	study	NN
cord-024716-1waejlwb	57	10	,	,	,
cord-024716-1waejlwb	57	11	the	the	DT
cord-024716-1waejlwb	57	12	incidence	incidence	NN
cord-024716-1waejlwb	57	13	of	of	IN
cord-024716-1waejlwb	57	14	tuberculosis	tuberculosis	NN
cord-024716-1waejlwb	57	15	is	be	VBZ
cord-024716-1waejlwb	57	16	≤20/1,000,000	≤20/1,000,000	NNP
cord-024716-1waejlwb	57	17	population	population	NN
cord-024716-1waejlwb	57	18	in	in	IN
cord-024716-1waejlwb	57	19	29	29	CD
cord-024716-1waejlwb	57	20	countries	country	NNS
cord-024716-1waejlwb	57	21	(	(	-LRB-
cord-024716-1waejlwb	57	22	Group	group	NN
cord-024716-1waejlwb	57	23	E	E	NNP
cord-024716-1waejlwb	57	24	)	)	-RRB-
cord-024716-1waejlwb	57	25	and	and	CC
cord-024716-1waejlwb	57	26	>	>	XX
cord-024716-1waejlwb	57	27	20/1,000,000	20/1,000,000	CD
cord-024716-1waejlwb	57	28	population	population	NN
cord-024716-1waejlwb	57	29	in	in	IN
cord-024716-1waejlwb	57	30	21	21	CD
cord-024716-1waejlwb	57	31	countries	country	NNS
cord-024716-1waejlwb	57	32	(	(	-LRB-
cord-024716-1waejlwb	57	33	Group	Group	NNP
cord-024716-1waejlwb	57	34	F	F	NNP
cord-024716-1waejlwb	57	35	)	)	-RRB-
cord-024716-1waejlwb	57	36	.	.	.
cord-024716-1waejlwb	58	1	The	the	DT
cord-024716-1waejlwb	58	2	difference	difference	NN
cord-024716-1waejlwb	58	3	between	between	IN
cord-024716-1waejlwb	58	4	the	the	DT
cord-024716-1waejlwb	58	5	"	"	``
cord-024716-1waejlwb	58	6	total	total	JJ
cord-024716-1waejlwb	58	7	number	number	NN
cord-024716-1waejlwb	58	8	of	of	IN
cord-024716-1waejlwb	58	9	cases	case	NNS
cord-024716-1waejlwb	58	10	per	per	IN
cord-024716-1waejlwb	58	11	million	million	CD
cord-024716-1waejlwb	58	12	population	population	NN
cord-024716-1waejlwb	58	13	"	"	''
cord-024716-1waejlwb	58	14	in	in	IN
cord-024716-1waejlwb	58	15	Group	Group	NNP
cord-024716-1waejlwb	58	16	E	E	NNP
cord-024716-1waejlwb	58	17	and	and	CC
cord-024716-1waejlwb	58	18	Group	Group	NNP
cord-024716-1waejlwb	58	19	F	F	NNP
cord-024716-1waejlwb	58	20	was	be	VBD
cord-024716-1waejlwb	58	21	statistically	statistically	RB
cord-024716-1waejlwb	58	22	significant	significant	JJ
cord-024716-1waejlwb	58	23	(	(	-LRB-
cord-024716-1waejlwb	58	24	P	p	NN
cord-024716-1waejlwb	58	25	<	<	XX
cord-024716-1waejlwb	58	26	0.001	0.001	CD
cord-024716-1waejlwb	58	27	)	)	-RRB-
cord-024716-1waejlwb	59	1	[	[	-LRB-
cord-024716-1waejlwb	59	2	Figure	figure	NN
cord-024716-1waejlwb	59	3	1c	1c	CD
cord-024716-1waejlwb	59	4	]	]	-RRB-
cord-024716-1waejlwb	59	5	.	.	.
cord-024716-1waejlwb	60	1	Besides	besides	RB
cord-024716-1waejlwb	60	2	,	,	,
cord-024716-1waejlwb	60	3	"	"	''
cord-024716-1waejlwb	60	4	the	the	DT
cord-024716-1waejlwb	60	5	total	total	JJ
cord-024716-1waejlwb	60	6	number	number	NN
cord-024716-1waejlwb	60	7	of	of	IN
cord-024716-1waejlwb	60	8	deaths	death	NNS
cord-024716-1waejlwb	60	9	per	per	IN
cord-024716-1waejlwb	60	10	million	million	CD
cord-024716-1waejlwb	60	11	population	population	NN
cord-024716-1waejlwb	60	12	"	"	''
cord-024716-1waejlwb	60	13	between	between	IN
cord-024716-1waejlwb	60	14	Groups	group	NNS
cord-024716-1waejlwb	60	15	E	E	NNP
cord-024716-1waejlwb	60	16	and	and	CC
cord-024716-1waejlwb	60	17	F	F	NNP
cord-024716-1waejlwb	60	18	was	be	VBD
cord-024716-1waejlwb	60	19	also	also	RB
cord-024716-1waejlwb	60	20	statistically	statistically	RB
cord-024716-1waejlwb	60	21	significant	significant	JJ
cord-024716-1waejlwb	60	22	(	(	-LRB-
cord-024716-1waejlwb	60	23	P	p	NN
cord-024716-1waejlwb	60	24	<	<	XX
cord-024716-1waejlwb	60	25	0.001	0.001	CD
cord-024716-1waejlwb	60	26	)	)	-RRB-
cord-024716-1waejlwb	61	1	[	[	-LRB-
cord-024716-1waejlwb	61	2	Figure	figure	NN
cord-024716-1waejlwb	61	3	1d	1d	CD
cord-024716-1waejlwb	61	4	and	and	CC
cord-024716-1waejlwb	61	5	Table	Table	NNP
cord-024716-1waejlwb	61	6	1	1	CD
cord-024716-1waejlwb	61	7	]	]	-RRB-
cord-024716-1waejlwb	61	8	.	.	.
cord-024716-1waejlwb	62	1	The	the	DT
cord-024716-1waejlwb	62	2	study	study	NN
cord-024716-1waejlwb	62	3	shows	show	VBZ
cord-024716-1waejlwb	62	4	that	that	IN
cord-024716-1waejlwb	62	5	there	there	EX
cord-024716-1waejlwb	62	6	are	be	VBP
cord-024716-1waejlwb	62	7	a	a	DT
cord-024716-1waejlwb	62	8	significantly	significantly	RB
cord-024716-1waejlwb	62	9	lower	low	JJR
cord-024716-1waejlwb	62	10	number	number	NN
cord-024716-1waejlwb	62	11	of	of	IN
cord-024716-1waejlwb	62	12	cases	case	NNS
cord-024716-1waejlwb	62	13	as	as	RB
cord-024716-1waejlwb	62	14	well	well	RB
cord-024716-1waejlwb	62	15	as	as	IN
cord-024716-1waejlwb	62	16	deaths	death	NNS
cord-024716-1waejlwb	62	17	in	in	IN
cord-024716-1waejlwb	62	18	countries	country	NNS
cord-024716-1waejlwb	62	19	where	where	WRB
cord-024716-1waejlwb	62	20	universal	universal	JJ
cord-024716-1waejlwb	62	21	BCG	BCG	NNP
cord-024716-1waejlwb	62	22	policy	policy	NN
cord-024716-1waejlwb	62	23	is	be	VBZ
cord-024716-1waejlwb	62	24	being	be	VBG
cord-024716-1waejlwb	62	25	practiced	practice	VBN
cord-024716-1waejlwb	62	26	.	.	.
cord-024716-1waejlwb	63	1	Hence	hence	RB
cord-024716-1waejlwb	63	2	,	,	,
cord-024716-1waejlwb	63	3	it	-PRON-	PRP
cord-024716-1waejlwb	63	4	can	can	MD
cord-024716-1waejlwb	63	5	be	be	VB
cord-024716-1waejlwb	63	6	possibly	possibly	RB
cord-024716-1waejlwb	63	7	concluded	conclude	VBN
cord-024716-1waejlwb	63	8	that	that	IN
cord-024716-1waejlwb	63	9	BCG	BCG	NNP
cord-024716-1waejlwb	63	10	vaccination	vaccination	NN
cord-024716-1waejlwb	63	11	provides	provide	VBZ
cord-024716-1waejlwb	63	12	a	a	DT
cord-024716-1waejlwb	63	13	cross	cross	NN
cord-024716-1waejlwb	63	14	-	-	NN
cord-024716-1waejlwb	63	15	protection	protection	NN
cord-024716-1waejlwb	63	16	against	against	IN
cord-024716-1waejlwb	63	17	COVID-19	COVID-19	NNP
cord-024716-1waejlwb	63	18	.	.	.
cord-024716-1waejlwb	64	1	However	however	RB
cord-024716-1waejlwb	64	2	,	,	,
cord-024716-1waejlwb	64	3	a	a	DT
cord-024716-1waejlwb	64	4	detailed	detailed	JJ
cord-024716-1waejlwb	64	5	study	study	NN
cord-024716-1waejlwb	64	6	into	into	IN
cord-024716-1waejlwb	64	7	the	the	DT
cord-024716-1waejlwb	64	8	epidemiological	epidemiological	JJ
cord-024716-1waejlwb	64	9	parameters	parameter	NNS
cord-024716-1waejlwb	64	10	of	of	IN
cord-024716-1waejlwb	64	11	the	the	DT
cord-024716-1waejlwb	64	12	countries	country	NNS
cord-024716-1waejlwb	64	13	which	which	WDT
cord-024716-1waejlwb	64	14	had	have	VBD
cord-024716-1waejlwb	64	15	universal	universal	JJ
cord-024716-1waejlwb	64	16	BCG	BCG	NNP
cord-024716-1waejlwb	64	17	vaccination	vaccination	NN
cord-024716-1waejlwb	64	18	policy	policy	NN
cord-024716-1waejlwb	64	19	in	in	IN
cord-024716-1waejlwb	64	20	the	the	DT
cord-024716-1waejlwb	64	21	past	past	NN
cord-024716-1waejlwb	64	22	(	(	-LRB-
cord-024716-1waejlwb	64	23	but	but	CC
cord-024716-1waejlwb	64	24	have	have	VBP
cord-024716-1waejlwb	64	25	stopped	stop	VBN
cord-024716-1waejlwb	64	26	universal	universal	JJ
cord-024716-1waejlwb	64	27	BCG	BCG	NNP
cord-024716-1waejlwb	64	28	as	as	IN
cord-024716-1waejlwb	64	29	of	of	IN
cord-024716-1waejlwb	64	30	now	now	RB
cord-024716-1waejlwb	64	31	)	)	-RRB-
cord-024716-1waejlwb	64	32	revealed	reveal	VBN
cord-024716-1waejlwb	64	33	enigmatic	enigmatic	JJ
cord-024716-1waejlwb	64	34	result	result	NN
cord-024716-1waejlwb	64	35	.	.	.
cord-024716-1waejlwb	65	1	The	the	DT
cord-024716-1waejlwb	65	2	earliest	early	JJS
cord-024716-1waejlwb	65	3	to	to	TO
cord-024716-1waejlwb	65	4	stop	stop	VB
cord-024716-1waejlwb	65	5	universal	universal	JJ
cord-024716-1waejlwb	65	6	BCG	BCG	NNP
cord-024716-1waejlwb	65	7	was	be	VBD
cord-024716-1waejlwb	65	8	Sweden	Sweden	NNP
cord-024716-1waejlwb	65	9	which	which	WDT
cord-024716-1waejlwb	65	10	stopped	stop	VBD
cord-024716-1waejlwb	65	11	it	-PRON-	PRP
cord-024716-1waejlwb	65	12	in	in	IN
cord-024716-1waejlwb	65	13	1975	1975	CD
cord-024716-1waejlwb	65	14	.	.	.
cord-024716-1waejlwb	66	1	[	[	-LRB-
cord-024716-1waejlwb	66	2	3	3	LS
cord-024716-1waejlwb	66	3	]	]	-RRB-
cord-024716-1waejlwb	66	4	It	-PRON-	PRP
cord-024716-1waejlwb	66	5	means	mean	VBZ
cord-024716-1waejlwb	66	6	that	that	IN
cord-024716-1waejlwb	66	7	almost	almost	RB
cord-024716-1waejlwb	66	8	all	all	DT
cord-024716-1waejlwb	66	9	people	people	NNS
cord-024716-1waejlwb	66	10	aged	aged	JJ
cord-024716-1waejlwb	66	11	>	>	XX
cord-024716-1waejlwb	67	1	45	45	CD
cord-024716-1waejlwb	67	2	years	year	NNS
cord-024716-1waejlwb	67	3	in	in	IN
cord-024716-1waejlwb	67	4	Sweden	Sweden	NNP
cord-024716-1waejlwb	67	5	have	have	VBP
cord-024716-1waejlwb	67	6	received	receive	VBN
cord-024716-1waejlwb	67	7	BCG	BCG	NNP
cord-024716-1waejlwb	67	8	vaccination	vaccination	NN
cord-024716-1waejlwb	67	9	in	in	IN
cord-024716-1waejlwb	67	10	their	-PRON-	PRP$
cord-024716-1waejlwb	67	11	childhood	childhood	NN
cord-024716-1waejlwb	67	12	.	.	.
cord-024716-1waejlwb	68	1	In	in	IN
cord-024716-1waejlwb	68	2	fact	fact	NN
cord-024716-1waejlwb	68	3	,	,	,
cord-024716-1waejlwb	68	4	most	most	JJS
cord-024716-1waejlwb	68	5	of	of	IN
cord-024716-1waejlwb	68	6	these	these	DT
cord-024716-1waejlwb	68	7	countries	country	NNS
cord-024716-1waejlwb	68	8	have	have	VBP
cord-024716-1waejlwb	68	9	stopped	stop	VBN
cord-024716-1waejlwb	68	10	universal	universal	JJ
cord-024716-1waejlwb	68	11	BCG	BCG	NNP
cord-024716-1waejlwb	68	12	vaccination	vaccination	NN
cord-024716-1waejlwb	68	13	around	around	IN
cord-024716-1waejlwb	68	14	the	the	DT
cord-024716-1waejlwb	68	15	1990s	1990	NNS
cord-024716-1waejlwb	68	16	which	which	WDT
cord-024716-1waejlwb	68	17	means	mean	VBZ
cord-024716-1waejlwb	68	18	that	that	IN
cord-024716-1waejlwb	68	19	most	most	JJS
cord-024716-1waejlwb	68	20	of	of	IN
cord-024716-1waejlwb	68	21	the	the	DT
cord-024716-1waejlwb	68	22	people	people	NNS
cord-024716-1waejlwb	68	23	aged	age	VBN
cord-024716-1waejlwb	68	24	around	around	IN
cord-024716-1waejlwb	68	25	30	30	CD
cord-024716-1waejlwb	68	26	years	year	NNS
cord-024716-1waejlwb	68	27	or	or	CC
cord-024716-1waejlwb	68	28	more	more	JJR
cord-024716-1waejlwb	68	29	(	(	-LRB-
cord-024716-1waejlwb	68	30	in	in	IN
cord-024716-1waejlwb	68	31	these	these	DT
cord-024716-1waejlwb	68	32	countries	country	NNS
cord-024716-1waejlwb	68	33	)	)	-RRB-
cord-024716-1waejlwb	68	34	have	have	VBP
cord-024716-1waejlwb	68	35	received	receive	VBN
cord-024716-1waejlwb	68	36	BCG	BCG	NNP
cord-024716-1waejlwb	68	37	vaccination	vaccination	NN
cord-024716-1waejlwb	68	38	in	in	IN
cord-024716-1waejlwb	68	39	their	-PRON-	PRP$
cord-024716-1waejlwb	68	40	childhood	childhood	NN
cord-024716-1waejlwb	68	41	.	.	.
cord-024716-1waejlwb	69	1	France	France	NNP
cord-024716-1waejlwb	69	2	is	be	VBZ
cord-024716-1waejlwb	69	3	one	one	CD
cord-024716-1waejlwb	69	4	of	of	IN
cord-024716-1waejlwb	69	5	the	the	DT
cord-024716-1waejlwb	69	6	last	last	JJ
cord-024716-1waejlwb	69	7	countries	country	NNS
cord-024716-1waejlwb	69	8	to	to	TO
cord-024716-1waejlwb	69	9	have	have	VB
cord-024716-1waejlwb	69	10	stopped	stop	VBN
cord-024716-1waejlwb	69	11	universal	universal	JJ
cord-024716-1waejlwb	69	12	BCG	BCG	NNP
cord-024716-1waejlwb	69	13	in	in	IN
cord-024716-1waejlwb	69	14	the	the	DT
cord-024716-1waejlwb	69	15	year	year	NN
cord-024716-1waejlwb	69	16	2007	2007	CD
cord-024716-1waejlwb	69	17	.	.	.
cord-024716-1waejlwb	70	1	[	[	-LRB-
cord-024716-1waejlwb	70	2	3	3	CD
cord-024716-1waejlwb	70	3	]	]	-RRB-
cord-024716-1waejlwb	71	1	As	as	IN
cord-024716-1waejlwb	71	2	such	such	JJ
cord-024716-1waejlwb	71	3	,	,	,
cord-024716-1waejlwb	71	4	every	every	DT
cord-024716-1waejlwb	71	5	French	french	JJ
cord-024716-1waejlwb	71	6	citizen	citizen	NN
cord-024716-1waejlwb	71	7	>	>	XX
cord-024716-1waejlwb	72	1	13	13	CD
cord-024716-1waejlwb	72	2	years	year	NNS
cord-024716-1waejlwb	72	3	of	of	IN
cord-024716-1waejlwb	72	4	age	age	NN
cord-024716-1waejlwb	72	5	must	must	MD
cord-024716-1waejlwb	72	6	have	have	VB
cord-024716-1waejlwb	72	7	received	receive	VBN
cord-024716-1waejlwb	72	8	BCG	BCG	NNP
cord-024716-1waejlwb	72	9	vaccination	vaccination	NN
cord-024716-1waejlwb	72	10	,	,	,
cord-024716-1waejlwb	72	11	but	but	CC
cord-024716-1waejlwb	72	12	even	even	RB
cord-024716-1waejlwb	72	13	then	then	RB
cord-024716-1waejlwb	72	14	France	France	NNP
cord-024716-1waejlwb	72	15	ranks	rank	VBZ
cord-024716-1waejlwb	72	16	4	4	CD
cord-024716-1waejlwb	72	17	th	th	XX
cord-024716-1waejlwb	72	18	in	in	IN
cord-024716-1waejlwb	72	19	the	the	DT
cord-024716-1waejlwb	72	20	total	total	JJ
cord-024716-1waejlwb	72	21	number	number	NN
cord-024716-1waejlwb	72	22	of	of	IN
cord-024716-1waejlwb	72	23	cases	case	NNS
cord-024716-1waejlwb	72	24	per	per	IN
cord-024716-1waejlwb	72	25	million	million	CD
cord-024716-1waejlwb	72	26	population	population	NN
cord-024716-1waejlwb	72	27	(	(	-LRB-
cord-024716-1waejlwb	72	28	only	only	RB
cord-024716-1waejlwb	72	29	after	after	IN
cord-024716-1waejlwb	72	30	Italy	Italy	NNP
cord-024716-1waejlwb	72	31	,	,	,
cord-024716-1waejlwb	72	32	Spain	Spain	NNP
cord-024716-1waejlwb	72	33	,	,	,
cord-024716-1waejlwb	72	34	and	and	CC
cord-024716-1waejlwb	72	35	the	the	DT
cord-024716-1waejlwb	72	36	US	US	NNP
cord-024716-1waejlwb	72	37	)	)	-RRB-
cord-024716-1waejlwb	72	38	.	.	.
cord-024716-1waejlwb	73	1	[	[	-LRB-
cord-024716-1waejlwb	73	2	1	1	CD
cord-024716-1waejlwb	73	3	]	]	-RRB-
cord-024716-1waejlwb	74	1	The	the	DT
cord-024716-1waejlwb	74	2	study	study	NN
cord-024716-1waejlwb	74	3	also	also	RB
cord-024716-1waejlwb	74	4	shows	show	VBZ
cord-024716-1waejlwb	74	5	that	that	IN
cord-024716-1waejlwb	74	6	the	the	DT
cord-024716-1waejlwb	74	7	"	"	``
cord-024716-1waejlwb	74	8	total	total	JJ
cord-024716-1waejlwb	74	9	number	number	NN
cord-024716-1waejlwb	74	10	of	of	IN
cord-024716-1waejlwb	74	11	cases	case	NNS
cord-024716-1waejlwb	74	12	"	"	''
cord-024716-1waejlwb	74	13	as	as	RB
cord-024716-1waejlwb	74	14	well	well	RB
cord-024716-1waejlwb	74	15	as	as	IN
cord-024716-1waejlwb	74	16	"	"	``
cord-024716-1waejlwb	74	17	the	the	DT
cord-024716-1waejlwb	74	18	total	total	JJ
cord-024716-1waejlwb	74	19	number	number	NN
cord-024716-1waejlwb	74	20	of	of	IN
cord-024716-1waejlwb	74	21	deaths	death	NNS
cord-024716-1waejlwb	74	22	"	"	''
cord-024716-1waejlwb	74	23	per	per	IN
cord-024716-1waejlwb	74	24	million	million	CD
cord-024716-1waejlwb	74	25	are	be	VBP
cord-024716-1waejlwb	74	26	significantly	significantly	RB
cord-024716-1waejlwb	74	27	lower	low	JJR
cord-024716-1waejlwb	74	28	in	in	IN
cord-024716-1waejlwb	74	29	countries	country	NNS
cord-024716-1waejlwb	74	30	with	with	IN
cord-024716-1waejlwb	74	31	a	a	DT
cord-024716-1waejlwb	74	32	high	high	JJ
cord-024716-1waejlwb	74	33	incidence	incidence	NN
cord-024716-1waejlwb	74	34	of	of	IN
cord-024716-1waejlwb	74	35	tuberculosis	tuberculosis	NN
cord-024716-1waejlwb	74	36	.	.	.
cord-024716-1waejlwb	75	1	It	-PRON-	PRP
cord-024716-1waejlwb	75	2	must	must	MD
cord-024716-1waejlwb	75	3	be	be	VB
cord-024716-1waejlwb	75	4	remembered	remember	VBN
cord-024716-1waejlwb	75	5	that	that	IN
cord-024716-1waejlwb	75	6	not	not	RB
cord-024716-1waejlwb	75	7	all	all	DT
cord-024716-1waejlwb	75	8	countries	country	NNS
cord-024716-1waejlwb	75	9	with	with	IN
cord-024716-1waejlwb	75	10	a	a	DT
cord-024716-1waejlwb	75	11	high	high	JJ
cord-024716-1waejlwb	75	12	incidence	incidence	NN
cord-024716-1waejlwb	75	13	of	of	IN
cord-024716-1waejlwb	75	14	tuberculosis	tuberculosis	NN
cord-024716-1waejlwb	75	15	are	be	VBP
cord-024716-1waejlwb	75	16	practicing	practice	VBG
cord-024716-1waejlwb	75	17	universal	universal	JJ
cord-024716-1waejlwb	75	18	vaccination	vaccination	NN
cord-024716-1waejlwb	75	19	(	(	-LRB-
cord-024716-1waejlwb	75	20	for	for	IN
cord-024716-1waejlwb	75	21	example	example	NN
cord-024716-1waejlwb	75	22	,	,	,
cord-024716-1waejlwb	75	23	Ecuador	Ecuador	NNP
cord-024716-1waejlwb	75	24	has	have	VBZ
cord-024716-1waejlwb	75	25	an	an	DT
cord-024716-1waejlwb	75	26	incidence	incidence	NN
cord-024716-1waejlwb	75	27	of	of	IN
cord-024716-1waejlwb	75	28	52/1,000,000	52/1,000,000	CD
cord-024716-1waejlwb	75	29	,	,	,
cord-024716-1waejlwb	75	30	but	but	CC
cord-024716-1waejlwb	75	31	has	have	VBZ
cord-024716-1waejlwb	75	32	no	no	DT
cord-024716-1waejlwb	75	33	universal	universal	JJ
cord-024716-1waejlwb	75	34	BCG	BCG	NNP
cord-024716-1waejlwb	75	35	policy	policy	NN
cord-024716-1waejlwb	75	36	)	)	-RRB-
cord-024716-1waejlwb	75	37	and	and	CC
cord-024716-1waejlwb	75	38	not	not	RB
cord-024716-1waejlwb	75	39	all	all	DT
cord-024716-1waejlwb	75	40	countries	country	NNS
cord-024716-1waejlwb	75	41	with	with	IN
cord-024716-1waejlwb	75	42	low	low	JJ
cord-024716-1waejlwb	75	43	incidence	incidence	NN
cord-024716-1waejlwb	75	44	of	of	IN
cord-024716-1waejlwb	75	45	tuberculosis	tuberculosis	NN
cord-024716-1waejlwb	75	46	have	have	VBP
cord-024716-1waejlwb	75	47	stopped	stop	VBN
cord-024716-1waejlwb	75	48	giving	give	VBG
cord-024716-1waejlwb	75	49	universal	universal	JJ
cord-024716-1waejlwb	75	50	BCG	BCG	NNP
cord-024716-1waejlwb	75	51	(	(	-LRB-
cord-024716-1waejlwb	75	52	for	for	IN
cord-024716-1waejlwb	75	53	example	example	NN
cord-024716-1waejlwb	75	54	,	,	,
cord-024716-1waejlwb	75	55	Hungary	Hungary	NNP
cord-024716-1waejlwb	75	56	,	,	,
cord-024716-1waejlwb	75	57	Ireland	Ireland	NNP
cord-024716-1waejlwb	75	58	,	,	,
cord-024716-1waejlwb	75	59	Greece	Greece	NNP
cord-024716-1waejlwb	75	60	,	,	,
cord-024716-1waejlwb	75	61	etc	etc	FW
cord-024716-1waejlwb	75	62	.	.	.
cord-024716-1waejlwb	75	63	)	)	-RRB-
cord-024716-1waejlwb	75	64	.	.	.
cord-024716-1waejlwb	76	1	[	[	-LRB-
cord-024716-1waejlwb	76	2	3	3	CD
cord-024716-1waejlwb	76	3	]	]	-RRB-
cord-024716-1waejlwb	77	1	In	in	IN
cord-024716-1waejlwb	77	2	fact	fact	NN
cord-024716-1waejlwb	77	3	,	,	,
cord-024716-1waejlwb	77	4	no	no	DT
cord-024716-1waejlwb	77	5	significant	significant	JJ
cord-024716-1waejlwb	77	6	difference	difference	NN
cord-024716-1waejlwb	77	7	in	in	IN
cord-024716-1waejlwb	77	8	COVID-19	covid-19	JJ
cord-024716-1waejlwb	77	9	parameters	parameter	NNS
cord-024716-1waejlwb	77	10	was	be	VBD
cord-024716-1waejlwb	77	11	observed	observe	VBN
cord-024716-1waejlwb	77	12	between	between	IN
cord-024716-1waejlwb	77	13	countries	country	NNS
cord-024716-1waejlwb	77	14	where	where	WRB
cord-024716-1waejlwb	77	15	was	be	VBD
cord-024716-1waejlwb	77	16	never	never	RB
cord-024716-1waejlwb	77	17	a	a	DT
cord-024716-1waejlwb	77	18	universal	universal	JJ
cord-024716-1waejlwb	77	19	BCG	BCG	NNP
cord-024716-1waejlwb	77	20	policy	policy	NN
cord-024716-1waejlwb	77	21	versus	versus	IN
cord-024716-1waejlwb	77	22	countries	country	NNS
cord-024716-1waejlwb	77	23	which	which	WDT
cord-024716-1waejlwb	77	24	have	have	VBP
cord-024716-1waejlwb	77	25	recently	recently	RB
cord-024716-1waejlwb	77	26	stopped	stop	VBN
cord-024716-1waejlwb	77	27	universal	universal	JJ
cord-024716-1waejlwb	77	28	BCG	BCG	NNP
cord-024716-1waejlwb	77	29	.	.	.
cord-024716-1waejlwb	78	1	Surprisingly	surprisingly	RB
cord-024716-1waejlwb	78	2	,	,	,
cord-024716-1waejlwb	78	3	COVID-19	covid-19	JJ
cord-024716-1waejlwb	78	4	infection	infection	NN
cord-024716-1waejlwb	78	5	rates	rate	NNS
cord-024716-1waejlwb	78	6	and	and	CC
cord-024716-1waejlwb	78	7	death	death	NN
cord-024716-1waejlwb	78	8	rates	rate	NNS
cord-024716-1waejlwb	78	9	were	be	VBD
cord-024716-1waejlwb	78	10	significantly	significantly	RB
cord-024716-1waejlwb	78	11	lower	low	JJR
cord-024716-1waejlwb	78	12	in	in	IN
cord-024716-1waejlwb	78	13	countries	country	NNS
cord-024716-1waejlwb	78	14	with	with	IN
cord-024716-1waejlwb	78	15	a	a	DT
cord-024716-1waejlwb	78	16	higher	high	JJR
cord-024716-1waejlwb	78	17	incidence	incidence	NN
cord-024716-1waejlwb	78	18	of	of	IN
cord-024716-1waejlwb	78	19	tuberculosis	tuberculosis	NN
cord-024716-1waejlwb	78	20	,	,	,
cord-024716-1waejlwb	78	21	irrespective	irrespective	RB
cord-024716-1waejlwb	78	22	of	of	IN
cord-024716-1waejlwb	78	23	whether	whether	IN
cord-024716-1waejlwb	78	24	universal	universal	JJ
cord-024716-1waejlwb	78	25	BCG	BCG	NNP
cord-024716-1waejlwb	78	26	is	be	VBZ
cord-024716-1waejlwb	78	27	given	give	VBN
cord-024716-1waejlwb	78	28	there	there	RB
cord-024716-1waejlwb	78	29	or	or	CC
cord-024716-1waejlwb	78	30	not	not	RB
cord-024716-1waejlwb	78	31	.	.	.
cord-024716-1waejlwb	79	1	BCG	BCG	NNP
cord-024716-1waejlwb	79	2	provided	provide	VBD
cord-024716-1waejlwb	79	3	heterologous	heterologous	JJ
cord-024716-1waejlwb	79	4	or	or	CC
cord-024716-1waejlwb	79	5	non	non	JJ
cord-024716-1waejlwb	79	6	-	-	JJ
cord-024716-1waejlwb	79	7	specific	specific	JJ
cord-024716-1waejlwb	79	8	immunity	immunity	NN
cord-024716-1waejlwb	79	9	against	against	IN
cord-024716-1waejlwb	79	10	a	a	DT
cord-024716-1waejlwb	79	11	host	host	NN
cord-024716-1waejlwb	79	12	of	of	IN
cord-024716-1waejlwb	79	13	non	non	JJ
cord-024716-1waejlwb	79	14	-	-	JJ
cord-024716-1waejlwb	79	15	mycobacterial	mycobacterial	JJ
cord-024716-1waejlwb	79	16	disease	disease	NN
cord-024716-1waejlwb	79	17	conditions	condition	NNS
cord-024716-1waejlwb	79	18	such	such	JJ
cord-024716-1waejlwb	79	19	as	as	IN
cord-024716-1waejlwb	79	20	viral	viral	JJ
cord-024716-1waejlwb	79	21	infections	infection	NNS
cord-024716-1waejlwb	79	22	and	and	CC
cord-024716-1waejlwb	79	23	sepsis	sepsis	NN
cord-024716-1waejlwb	79	24	.	.	.
cord-024716-1waejlwb	80	1	[	[	-LRB-
cord-024716-1waejlwb	80	2	4	4	CD
cord-024716-1waejlwb	80	3	]	]	-RRB-
cord-024716-1waejlwb	81	1	In	in	IN
cord-024716-1waejlwb	81	2	a	a	DT
cord-024716-1waejlwb	81	3	study	study	NN
cord-024716-1waejlwb	81	4	in	in	IN
cord-024716-1waejlwb	81	5	West	West	NNP
cord-024716-1waejlwb	81	6	Africa	Africa	NNP
cord-024716-1waejlwb	81	7	,	,	,
cord-024716-1waejlwb	81	8	Kristensen	Kristensen	NNP
cord-024716-1waejlwb	81	9	et	et	NNP
cord-024716-1waejlwb	81	10	al	al	NNP
cord-024716-1waejlwb	81	11	.	.	.
cord-024716-1waejlwb	82	1	found	find	VBD
cord-024716-1waejlwb	82	2	that	that	IN
cord-024716-1waejlwb	82	3	BCG	BCG	NNP
cord-024716-1waejlwb	82	4	provided	provide	VBD
cord-024716-1waejlwb	82	5	increased	increase	VBN
cord-024716-1waejlwb	82	6	survival	survival	NN
cord-024716-1waejlwb	82	7	in	in	IN
cord-024716-1waejlwb	82	8	children	child	NNS
cord-024716-1waejlwb	82	9	than	than	IN
cord-024716-1waejlwb	82	10	could	could	MD
cord-024716-1waejlwb	82	11	be	be	VB
cord-024716-1waejlwb	82	12	attributed	attribute	VBN
cord-024716-1waejlwb	82	13	to	to	IN
cord-024716-1waejlwb	82	14	the	the	DT
cord-024716-1waejlwb	82	15	protection	protection	NN
cord-024716-1waejlwb	82	16	against	against	IN
cord-024716-1waejlwb	82	17	only	only	JJ
cord-024716-1waejlwb	82	18	tuberculosis	tuberculosis	NN
cord-024716-1waejlwb	82	19	.	.	.
cord-024716-1waejlwb	83	1	[	[	-LRB-
cord-024716-1waejlwb	83	2	5	5	CD
cord-024716-1waejlwb	83	3	]	]	-RRB-
cord-024716-1waejlwb	83	4	BCG	BCG	NNP
cord-024716-1waejlwb	83	5	has	have	VBZ
cord-024716-1waejlwb	83	6	been	be	VBN
cord-024716-1waejlwb	83	7	shown	show	VBN
cord-024716-1waejlwb	83	8	to	to	TO
cord-024716-1waejlwb	83	9	induce	induce	VB
cord-024716-1waejlwb	83	10	T	t	NN
cord-024716-1waejlwb	83	11	-	-	HYPH
cord-024716-1waejlwb	83	12	cell	cell	NN
cord-024716-1waejlwb	83	13	-	-	HYPH
cord-024716-1waejlwb	83	14	independent	independent	JJ
cord-024716-1waejlwb	83	15	protection	protection	NN
cord-024716-1waejlwb	83	16	against	against	IN
cord-024716-1waejlwb	83	17	secondary	secondary	JJ
cord-024716-1waejlwb	83	18	infections	infection	NNS
cord-024716-1waejlwb	83	19	with	with	IN
cord-024716-1waejlwb	83	20	Candida	Candida	NNP
cord-024716-1waejlwb	83	21	albicans	albican	NNS
cord-024716-1waejlwb	83	22	or	or	CC
cord-024716-1waejlwb	83	23	Schistosoma	Schistosoma	NNP
cord-024716-1waejlwb	83	24	mansoni	mansoni	NNP
cord-024716-1waejlwb	83	25	in	in	IN
cord-024716-1waejlwb	83	26	mice	mouse	NNS
cord-024716-1waejlwb	83	27	.	.	.
cord-024716-1waejlwb	84	1	[	[	-LRB-
cord-024716-1waejlwb	84	2	6	6	CD
cord-024716-1waejlwb	84	3	]	]	-RRB-
cord-024716-1waejlwb	84	4	BCG	BCG	NNP
cord-024716-1waejlwb	84	5	is	be	VBZ
cord-024716-1waejlwb	84	6	also	also	RB
cord-024716-1waejlwb	84	7	known	know	VBN
cord-024716-1waejlwb	84	8	to	to	TO
cord-024716-1waejlwb	84	9	produce	produce	VB
cord-024716-1waejlwb	84	10	non	non	JJ
cord-024716-1waejlwb	84	11	-	-	JJ
cord-024716-1waejlwb	84	12	specific	specific	JJ
cord-024716-1waejlwb	84	13	protective	protective	JJ
cord-024716-1waejlwb	84	14	effects	effect	NNS
cord-024716-1waejlwb	84	15	through	through	IN
cord-024716-1waejlwb	84	16	innate	innate	JJ
cord-024716-1waejlwb	84	17	immunitydependent	immunitydependent	JJ
cord-024716-1waejlwb	84	18	mechanisms	mechanism	NNS
cord-024716-1waejlwb	84	19	in	in	IN
cord-024716-1waejlwb	84	20	malignancies	malignancy	NNS
cord-024716-1waejlwb	84	21	such	such	JJ
cord-024716-1waejlwb	84	22	as	as	IN
cord-024716-1waejlwb	84	23	bladder	bladder	NN
cord-024716-1waejlwb	84	24	cancer	cancer	NN
cord-024716-1waejlwb	84	25	,	,	,
cord-024716-1waejlwb	84	26	melanoma	melanoma	NN
cord-024716-1waejlwb	84	27	,	,	,
cord-024716-1waejlwb	84	28	leukemia	leukemia	NN
cord-024716-1waejlwb	84	29	,	,	,
cord-024716-1waejlwb	84	30	and	and	CC
cord-024716-1waejlwb	84	31	lymphoma	lymphoma	NN
cord-024716-1waejlwb	84	32	.	.	.
cord-024716-1waejlwb	85	1	[	[	-LRB-
cord-024716-1waejlwb	85	2	6	6	CD
cord-024716-1waejlwb	85	3	]	]	-RRB-
cord-024716-1waejlwb	85	4	Kleinnijenhuis	Kleinnijenhuis	NNP
cord-024716-1waejlwb	85	5	found	find	VBD
cord-024716-1waejlwb	85	6	that	that	IN
cord-024716-1waejlwb	85	7	BCG	BCG	NNP
cord-024716-1waejlwb	85	8	induces	induce	VBZ
cord-024716-1waejlwb	85	9	epigenetic	epigenetic	JJ
cord-024716-1waejlwb	85	10	reprogramming	reprogramming	NN
cord-024716-1waejlwb	85	11	of	of	IN
cord-024716-1waejlwb	85	12	monocytes	monocyte	NNS
cord-024716-1waejlwb	85	13	,	,	,
cord-024716-1waejlwb	85	14	thereby	thereby	RB
cord-024716-1waejlwb	85	15	resulting	result	VBG
cord-024716-1waejlwb	85	16	in	in	IN
cord-024716-1waejlwb	85	17	an	an	DT
cord-024716-1waejlwb	85	18	increase	increase	NN
cord-024716-1waejlwb	85	19	of	of	IN
cord-024716-1waejlwb	85	20	proinflammatory	proinflammatory	JJ
cord-024716-1waejlwb	85	21	cytokines	cytokine	NNS
cord-024716-1waejlwb	85	22	(	(	-LRB-
cord-024716-1waejlwb	85	23	particularly	particularly	RB
cord-024716-1waejlwb	85	24	,	,	,
cord-024716-1waejlwb	85	25	TNF	tnf	NN
cord-024716-1waejlwb	85	26	-	-	HYPH
cord-024716-1waejlwb	85	27	alpha	alpha	NN
cord-024716-1waejlwb	85	28	and	and	CC
cord-024716-1waejlwb	85	29	interleukin-1	interleukin-1	NN
cord-024716-1waejlwb	85	30	beta	beta	NN
cord-024716-1waejlwb	85	31	)	)	-RRB-
cord-024716-1waejlwb	85	32	production	production	NN
cord-024716-1waejlwb	85	33	in	in	IN
cord-024716-1waejlwb	85	34	response	response	NN
cord-024716-1waejlwb	85	35	to	to	IN
cord-024716-1waejlwb	85	36	non	non	JJ
cord-024716-1waejlwb	85	37	-	-	JJ
cord-024716-1waejlwb	85	38	related	related	JJ
cord-024716-1waejlwb	85	39	pathogens	pathogen	NNS
cord-024716-1waejlwb	85	40	.	.	.
cord-024716-1waejlwb	86	1	They	-PRON-	PRP
cord-024716-1waejlwb	86	2	concluded	conclude	VBD
cord-024716-1waejlwb	86	3	that	that	IN
cord-024716-1waejlwb	86	4	BCG	BCG	NNP
cord-024716-1waejlwb	86	5	produces	produce	VBZ
cord-024716-1waejlwb	86	6	sustained	sustained	JJ
cord-024716-1waejlwb	86	7	changes	change	NNS
cord-024716-1waejlwb	86	8	in	in	IN
cord-024716-1waejlwb	86	9	immune	immune	JJ
cord-024716-1waejlwb	86	10	system	system	NN
cord-024716-1waejlwb	86	11	,	,	,
cord-024716-1waejlwb	86	12	leading	lead	VBG
cord-024716-1waejlwb	86	13	to	to	IN
cord-024716-1waejlwb	86	14	a	a	DT
cord-024716-1waejlwb	86	15	non	non	JJ
cord-024716-1waejlwb	86	16	-	-	JJ
cord-024716-1waejlwb	86	17	specific	specific	JJ
cord-024716-1waejlwb	86	18	response	response	NN
cord-024716-1waejlwb	86	19	to	to	IN
cord-024716-1waejlwb	86	20	infections	infection	NNS
cord-024716-1waejlwb	86	21	both	both	CC
cord-024716-1waejlwb	86	22	at	at	IN
cord-024716-1waejlwb	86	23	the	the	DT
cord-024716-1waejlwb	86	24	level	level	NN
cord-024716-1waejlwb	86	25	of	of	IN
cord-024716-1waejlwb	86	26	innate	innate	JJ
cord-024716-1waejlwb	86	27	trained	train	VBN
cord-024716-1waejlwb	86	28	immunity	immunity	NN
cord-024716-1waejlwb	86	29	and	and	CC
cord-024716-1waejlwb	86	30	heterologous	heterologous	NN
cord-024716-1waejlwb	87	1	Th1	Th1	NNP
cord-024716-1waejlwb	87	2	/	/	SYM
cord-024716-1waejlwb	87	3	Th17	th17	CD
cord-024716-1waejlwb	87	4	responses	response	NNS
cord-024716-1waejlwb	87	5	.	.	.
cord-024716-1waejlwb	88	1	[	[	-LRB-
cord-024716-1waejlwb	88	2	7	7	CD
cord-024716-1waejlwb	88	3	]	]	-RRB-
cord-024716-1waejlwb	88	4	BCG	BCG	NNP
cord-024716-1waejlwb	88	5	also	also	RB
cord-024716-1waejlwb	88	6	causes	cause	VBZ
cord-024716-1waejlwb	88	7	the	the	DT
cord-024716-1waejlwb	88	8	activation	activation	NN
cord-024716-1waejlwb	88	9	of	of	IN
cord-024716-1waejlwb	88	10	NK	NK	NNP
cord-024716-1waejlwb	88	11	cells	cell	NNS
cord-024716-1waejlwb	88	12	,	,	,
cord-024716-1waejlwb	88	13	leading	lead	VBG
cord-024716-1waejlwb	88	14	to	to	IN
cord-024716-1waejlwb	88	15	increased	increase	VBN
cord-024716-1waejlwb	88	16	production	production	NN
cord-024716-1waejlwb	88	17	of	of	IN
cord-024716-1waejlwb	88	18	proinflammatory	proinflammatory	JJ
cord-024716-1waejlwb	88	19	cytokine	cytokine	NN
cord-024716-1waejlwb	88	20	in	in	IN
cord-024716-1waejlwb	88	21	response	response	NN
cord-024716-1waejlwb	88	22	to	to	IN
cord-024716-1waejlwb	88	23	mycobacteria	mycobacterium	NNS
cord-024716-1waejlwb	88	24	and	and	CC
cord-024716-1waejlwb	88	25	other	other	JJ
cord-024716-1waejlwb	88	26	unrelated	unrelated	JJ
cord-024716-1waejlwb	88	27	pathogens	pathogen	NNS
cord-024716-1waejlwb	88	28	.	.	.
cord-024716-1waejlwb	89	1	It	-PRON-	PRP
cord-024716-1waejlwb	89	2	has	have	VBZ
cord-024716-1waejlwb	89	3	previously	previously	RB
cord-024716-1waejlwb	89	4	been	be	VBN
cord-024716-1waejlwb	89	5	shown	show	VBN
cord-024716-1waejlwb	89	6	that	that	IN
cord-024716-1waejlwb	89	7	BCG	BCG	NNP
cord-024716-1waejlwb	89	8	provides	provide	VBZ
cord-024716-1waejlwb	89	9	non	non	JJ
cord-024716-1waejlwb	89	10	-	-	JJ
cord-024716-1waejlwb	89	11	specific	specific	JJ
cord-024716-1waejlwb	89	12	protection	protection	NN
cord-024716-1waejlwb	89	13	against	against	IN
cord-024716-1waejlwb	89	14	C.	C.	NNP
cord-024716-1waejlwb	89	15	albicans	albican	NNS
cord-024716-1waejlwb	89	16	in	in	IN
cord-024716-1waejlwb	89	17	mice	mouse	NNS
cord-024716-1waejlwb	89	18	at	at	IN
cord-024716-1waejlwb	89	19	least	least	JJS
cord-024716-1waejlwb	89	20	partially	partially	RB
cord-024716-1waejlwb	89	21	through	through	IN
cord-024716-1waejlwb	89	22	NK	NK	NNP
cord-024716-1waejlwb	89	23	cells	cell	NNS
cord-024716-1waejlwb	89	24	.	.	.
cord-024716-1waejlwb	90	1	BCG	BCG	NNP
cord-024716-1waejlwb	90	2	produces	produce	VBZ
cord-024716-1waejlwb	90	3	an	an	DT
cord-024716-1waejlwb	90	4	increase	increase	NN
cord-024716-1waejlwb	90	5	in	in	IN
cord-024716-1waejlwb	90	6	inflammatory	inflammatory	JJ
cord-024716-1waejlwb	90	7	mediators	mediator	NNS
cord-024716-1waejlwb	90	8	from	from	IN
cord-024716-1waejlwb	90	9	monocytes	monocyte	NNS
cord-024716-1waejlwb	90	10	in	in	IN
cord-024716-1waejlwb	90	11	healthy	healthy	JJ
cord-024716-1waejlwb	90	12	volunteers	volunteer	NNS
cord-024716-1waejlwb	90	13	,	,	,
cord-024716-1waejlwb	90	14	which	which	WDT
cord-024716-1waejlwb	90	15	correlated	correlate	VBD
cord-024716-1waejlwb	90	16	with	with	IN
cord-024716-1waejlwb	90	17	parallel	parallel	JJ
cord-024716-1waejlwb	90	18	changes	change	NNS
cord-024716-1waejlwb	90	19	in	in	IN
cord-024716-1waejlwb	90	20	a	a	DT
cord-024716-1waejlwb	90	21	histone	histone	NN
cord-024716-1waejlwb	90	22	modification	modification	NN
cord-024716-1waejlwb	90	23	associated	associate	VBN
cord-024716-1waejlwb	90	24	with	with	IN
cord-024716-1waejlwb	90	25	gene	gene	NN
cord-024716-1waejlwb	90	26	activation	activation	NN
cord-024716-1waejlwb	90	27	.	.	.
cord-024716-1waejlwb	91	1	Hence	hence	RB
cord-024716-1waejlwb	91	2	,	,	,
cord-024716-1waejlwb	91	3	these	these	DT
cord-024716-1waejlwb	91	4	non	non	JJ
cord-024716-1waejlwb	91	5	-	-	JJ
cord-024716-1waejlwb	91	6	specific	specific	JJ
cord-024716-1waejlwb	91	7	(	(	-LRB-
cord-024716-1waejlwb	91	8	or	or	CC
cord-024716-1waejlwb	91	9	heterologous	heterologous	JJ
cord-024716-1waejlwb	91	10	)	)	-RRB-
cord-024716-1waejlwb	91	11	effects	effect	NNS
cord-024716-1waejlwb	91	12	show	show	VBP
cord-024716-1waejlwb	91	13	that	that	IN
cord-024716-1waejlwb	91	14	BCG	BCG	NNP
cord-024716-1waejlwb	91	15	induces	induce	VBZ
cord-024716-1waejlwb	91	16	trained	train	VBN
cord-024716-1waejlwb	91	17	immunity	immunity	NN
cord-024716-1waejlwb	91	18	that	that	WDT
cord-024716-1waejlwb	91	19	protects	protect	VBZ
cord-024716-1waejlwb	91	20	against	against	IN
cord-024716-1waejlwb	91	21	unrelated	unrelated	JJ
cord-024716-1waejlwb	91	22	pathogens	pathogen	NNS
cord-024716-1waejlwb	91	23	.	.	.
cord-024716-1waejlwb	92	1	Whether	whether	IN
cord-024716-1waejlwb	92	2	other	other	JJ
cord-024716-1waejlwb	92	3	mycobacterial	mycobacterial	JJ
cord-024716-1waejlwb	92	4	infections	infection	NNS
cord-024716-1waejlwb	92	5	(	(	-LRB-
cord-024716-1waejlwb	92	6	for	for	IN
cord-024716-1waejlwb	92	7	example	example	NN
cord-024716-1waejlwb	92	8	,	,	,
cord-024716-1waejlwb	92	9	latent	latent	JJ
cord-024716-1waejlwb	92	10	or	or	CC
cord-024716-1waejlwb	92	11	subclinical	subclinical	JJ
cord-024716-1waejlwb	92	12	tuberculosis	tuberculosis	NN
cord-024716-1waejlwb	92	13	)	)	-RRB-
cord-024716-1waejlwb	92	14	provide	provide	VBP
cord-024716-1waejlwb	92	15	any	any	DT
cord-024716-1waejlwb	92	16	cross	cross	NN
cord-024716-1waejlwb	92	17	-	-	NN
cord-024716-1waejlwb	92	18	protection	protection	NN
cord-024716-1waejlwb	92	19	against	against	IN
cord-024716-1waejlwb	92	20	COVID-19	covid-19	CD
cord-024716-1waejlwb	92	21	or	or	CC
cord-024716-1waejlwb	92	22	other	other	JJ
cord-024716-1waejlwb	92	23	unrelated	unrelated	JJ
cord-024716-1waejlwb	92	24	infections	infection	NNS
cord-024716-1waejlwb	92	25	are	be	VBP
cord-024716-1waejlwb	92	26	a	a	DT
cord-024716-1waejlwb	92	27	matter	matter	NN
cord-024716-1waejlwb	92	28	of	of	IN
cord-024716-1waejlwb	92	29	conjecture	conjecture	NN
cord-024716-1waejlwb	92	30	.	.	.
cord-024716-1waejlwb	93	1	The	the	DT
cord-024716-1waejlwb	93	2	medical	medical	JJ
cord-024716-1waejlwb	93	3	literature	literature	NN
cord-024716-1waejlwb	93	4	is	be	VBZ
cord-024716-1waejlwb	93	5	excessively	excessively	RB
cord-024716-1waejlwb	93	6	scanty	scanty	JJ
cord-024716-1waejlwb	93	7	in	in	IN
cord-024716-1waejlwb	93	8	that	that	DT
cord-024716-1waejlwb	93	9	regard	regard	NN
cord-024716-1waejlwb	93	10	.	.	.
cord-024716-1waejlwb	94	1	However	however	RB
cord-024716-1waejlwb	94	2	,	,	,
cord-024716-1waejlwb	94	3	Tarancon	Tarancon	NNP
cord-024716-1waejlwb	94	4	et	et	NNP
cord-024716-1waejlwb	94	5	al	al	NNP
cord-024716-1waejlwb	94	6	.	.	NNP
cord-024716-1waejlwb	94	7	found	find	VBD
cord-024716-1waejlwb	94	8	that	that	IN
cord-024716-1waejlwb	94	9	MTBVAC	MTBVAC	NNP
cord-024716-1waejlwb	94	10	,	,	,
cord-024716-1waejlwb	94	11	genetically	genetically	RB
cord-024716-1waejlwb	94	12	modified	modify	VBN
cord-024716-1waejlwb	94	13	form	form	NN
cord-024716-1waejlwb	94	14	of	of	IN
cord-024716-1waejlwb	94	15	M.	M.	NNP
cord-024716-1waejlwb	94	16	tuberculosis	tuberculosis	NN
cord-024716-1waejlwb	94	17	,	,	,
cord-024716-1waejlwb	94	18	is	be	VBZ
cord-024716-1waejlwb	94	19	able	able	JJ
cord-024716-1waejlwb	94	20	to	to	TO
cord-024716-1waejlwb	94	21	produce	produce	VB
cord-024716-1waejlwb	94	22	trained	train	VBN
cord-024716-1waejlwb	94	23	immunity	immunity	NN
cord-024716-1waejlwb	94	24	.	.	.
cord-024716-1waejlwb	95	1	[	[	-LRB-
cord-024716-1waejlwb	95	2	8	8	CD
cord-024716-1waejlwb	95	3	]	]	-RRB-
cord-024716-1waejlwb	95	4	Baldridge	Baldridge	NNP
cord-024716-1waejlwb	95	5	et	et	NNP
cord-024716-1waejlwb	95	6	al	al	NNP
cord-024716-1waejlwb	95	7	.	.	.
cord-024716-1waejlwb	96	1	showed	show	VBD
cord-024716-1waejlwb	96	2	that	that	IN
cord-024716-1waejlwb	96	3	during	during	IN
cord-024716-1waejlwb	96	4	an	an	DT
cord-024716-1waejlwb	96	5	infection	infection	NN
cord-024716-1waejlwb	96	6	with	with	IN
cord-024716-1waejlwb	96	7	Mycobacterium	Mycobacterium	NNP
cord-024716-1waejlwb	96	8	avium	avium	NN
cord-024716-1waejlwb	96	9	,	,	,
cord-024716-1waejlwb	96	10	there	there	EX
cord-024716-1waejlwb	96	11	is	be	VBZ
cord-024716-1waejlwb	96	12	an	an	DT
cord-024716-1waejlwb	96	13	increased	increase	VBN
cord-024716-1waejlwb	96	14	proliferation	proliferation	NN
cord-024716-1waejlwb	96	15	of	of	IN
cord-024716-1waejlwb	96	16	long	long	JJ
cord-024716-1waejlwb	96	17	-	-	HYPH
cord-024716-1waejlwb	96	18	term	term	NN
cord-024716-1waejlwb	96	19	repopulating	repopulate	VBG
cord-024716-1waejlwb	96	20	hematopoietic	hematopoietic	JJ
cord-024716-1waejlwb	96	21	stem	stem	NN
cord-024716-1waejlwb	96	22	cells	cell	NNS
cord-024716-1waejlwb	96	23	,	,	,
cord-024716-1waejlwb	96	24	a	a	DT
cord-024716-1waejlwb	96	25	response	response	NN
cord-024716-1waejlwb	96	26	that	that	WDT
cord-024716-1waejlwb	96	27	requires	require	VBZ
cord-024716-1waejlwb	96	28	increased	increase	VBN
cord-024716-1waejlwb	96	29	interferon	interferon	NN
cord-024716-1waejlwb	96	30	-	-	HYPH
cord-024716-1waejlwb	96	31	gamma	gamma	NN
cord-024716-1waejlwb	96	32	(	(	-LRB-
cord-024716-1waejlwb	96	33	IFNγ	IFNγ	NNS
cord-024716-1waejlwb	96	34	)	)	-RRB-
cord-024716-1waejlwb	96	35	signaling	signal	VBG
cord-024716-1waejlwb	96	36	.	.	.
cord-024716-1waejlwb	97	1	[	[	-LRB-
cord-024716-1waejlwb	97	2	9	9	CD
cord-024716-1waejlwb	97	3	]	]	-RRB-
cord-024716-1waejlwb	97	4	Khader	Khader	NNP
cord-024716-1waejlwb	97	5	et	et	NNP
cord-024716-1waejlwb	97	6	al	al	NNP
cord-024716-1waejlwb	97	7	.	.	.
cord-024716-1waejlwb	98	1	noted	note	VBD
cord-024716-1waejlwb	98	2	that	that	IN
cord-024716-1waejlwb	98	3	innate	innate	JJ
cord-024716-1waejlwb	98	4	immune	immune	JJ
cord-024716-1waejlwb	98	5	cells	cell	NNS
cord-024716-1waejlwb	98	6	,	,	,
cord-024716-1waejlwb	98	7	namely	namely	RB
cord-024716-1waejlwb	98	8	,	,	,
cord-024716-1waejlwb	98	9	myeloid	myeloid	NN
cord-024716-1waejlwb	98	10	cells	cell	NNS
cord-024716-1waejlwb	98	11	and	and	CC
cord-024716-1waejlwb	98	12	NK	NK	NNP
cord-024716-1waejlwb	98	13	cells	cell	NNS
cord-024716-1waejlwb	98	14	undergo	undergo	VBP
cord-024716-1waejlwb	98	15	functional	functional	JJ
cord-024716-1waejlwb	98	16	adaptation	adaptation	NN
cord-024716-1waejlwb	98	17	(	(	-LRB-
cord-024716-1waejlwb	98	18	trained	train	VBN
cord-024716-1waejlwb	98	19	immunity	immunity	NN
cord-024716-1waejlwb	98	20	)	)	-RRB-
cord-024716-1waejlwb	98	21	after	after	IN
cord-024716-1waejlwb	98	22	infection	infection	NN
cord-024716-1waejlwb	98	23	(	(	-LRB-
cord-024716-1waejlwb	98	24	with	with	IN
cord-024716-1waejlwb	98	25	M.	M.	NNP
cord-024716-1waejlwb	98	26	tuberculosis	tuberculosis	NN
cord-024716-1waejlwb	98	27	)	)	-RRB-
cord-024716-1waejlwb	98	28	or	or	CC
cord-024716-1waejlwb	98	29	vaccination	vaccination	NN
cord-024716-1waejlwb	98	30	with	with	IN
cord-024716-1waejlwb	98	31	BCG	BCG	NNP
cord-024716-1waejlwb	98	32	.	.	.
cord-024716-1waejlwb	99	1	[	[	-LRB-
cord-024716-1waejlwb	99	2	10	10	CD
cord-024716-1waejlwb	99	3	]	]	-RRB-
cord-024716-1waejlwb	100	1	Besides	besides	RB
cord-024716-1waejlwb	100	2	,	,	,
cord-024716-1waejlwb	100	3	it	-PRON-	PRP
cord-024716-1waejlwb	100	4	is	be	VBZ
cord-024716-1waejlwb	100	5	well	well	RB
cord-024716-1waejlwb	100	6	known	know	VBN
cord-024716-1waejlwb	100	7	that	that	IN
cord-024716-1waejlwb	100	8	various	various	JJ
cord-024716-1waejlwb	100	9	infections	infection	NNS
cord-024716-1waejlwb	100	10	like	like	IN
cord-024716-1waejlwb	100	11	malaria	malaria	NN
cord-024716-1waejlwb	100	12	can	can	MD
cord-024716-1waejlwb	100	13	also	also	RB
cord-024716-1waejlwb	100	14	induce	induce	VB
cord-024716-1waejlwb	100	15	a	a	DT
cord-024716-1waejlwb	100	16	state	state	NN
cord-024716-1waejlwb	100	17	of	of	IN
cord-024716-1waejlwb	100	18	hyperresponsiveness	hyperresponsiveness	NN
cord-024716-1waejlwb	100	19	that	that	WDT
cord-024716-1waejlwb	100	20	is	be	VBZ
cord-024716-1waejlwb	100	21	functionally	functionally	RB
cord-024716-1waejlwb	100	22	equivalent	equivalent	JJ
cord-024716-1waejlwb	100	23	to	to	IN
cord-024716-1waejlwb	100	24	the	the	DT
cord-024716-1waejlwb	100	25	induction	induction	NN
cord-024716-1waejlwb	100	26	of	of	IN
cord-024716-1waejlwb	100	27	trained	train	VBN
cord-024716-1waejlwb	100	28	immunity	immunity	NN
cord-024716-1waejlwb	100	29	.	.	.
cord-024716-1waejlwb	101	1	For	for	IN
cord-024716-1waejlwb	101	2	example	example	NN
cord-024716-1waejlwb	101	3	,	,	,
cord-024716-1waejlwb	101	4	herpesvirus	herpesvirus	NN
cord-024716-1waejlwb	101	5	latency	latency	NN
cord-024716-1waejlwb	101	6	increases	increase	VBZ
cord-024716-1waejlwb	101	7	resistance	resistance	NN
cord-024716-1waejlwb	101	8	to	to	IN
cord-024716-1waejlwb	101	9	the	the	DT
cord-024716-1waejlwb	101	10	bacterial	bacterial	JJ
cord-024716-1waejlwb	101	11	pathogens	pathogen	NNS
cord-024716-1waejlwb	101	12	Listeria	Listeria	NNP
cord-024716-1waejlwb	101	13	monocytogenes	monocytogene	NNS
cord-024716-1waejlwb	101	14	and	and	CC
cord-024716-1waejlwb	101	15	Yersinia	Yersinia	NNP
cord-024716-1waejlwb	101	16	pestis	pestis	NN
cord-024716-1waejlwb	101	17	by	by	IN
cord-024716-1waejlwb	101	18	increased	increase	VBN
cord-024716-1waejlwb	101	19	production	production	NN
cord-024716-1waejlwb	101	20	of	of	IN
cord-024716-1waejlwb	101	21	IFNγ	IFNγ	NNS
cord-024716-1waejlwb	101	22	and	and	CC
cord-024716-1waejlwb	101	23	systemic	systemic	JJ
cord-024716-1waejlwb	101	24	activation	activation	NN
cord-024716-1waejlwb	101	25	of	of	IN
cord-024716-1waejlwb	101	26	macrophages	macrophage	NNS
cord-024716-1waejlwb	101	27	.	.	.
cord-024716-1waejlwb	102	1	[	[	-LRB-
cord-024716-1waejlwb	102	2	6	6	CD
cord-024716-1waejlwb	102	3	]	]	-RRB-
cord-024716-1waejlwb	102	4	Limitations	limitation	NNS
cord-024716-1waejlwb	102	5	The	the	DT
cord-024716-1waejlwb	102	6	health	health	NN
cord-024716-1waejlwb	102	7	-	-	HYPH
cord-024716-1waejlwb	102	8	care	care	NN
cord-024716-1waejlwb	102	9	system	system	NN
cord-024716-1waejlwb	102	10	,	,	,
cord-024716-1waejlwb	102	11	COVID-19	covid-19	JJ
cord-024716-1waejlwb	102	12	testing	testing	NN
cord-024716-1waejlwb	102	13	rate	rate	NN
cord-024716-1waejlwb	102	14	,	,	,
cord-024716-1waejlwb	102	15	and	and	CC
cord-024716-1waejlwb	102	16	age	age	NN
cord-024716-1waejlwb	102	17	profile	profile	NN
cord-024716-1waejlwb	102	18	of	of	IN
cord-024716-1waejlwb	102	19	the	the	DT
cord-024716-1waejlwb	102	20	populations	population	NNS
cord-024716-1waejlwb	102	21	of	of	IN
cord-024716-1waejlwb	102	22	the	the	DT
cord-024716-1waejlwb	102	23	different	different	JJ
cord-024716-1waejlwb	102	24	countries	country	NNS
cord-024716-1waejlwb	102	25	may	may	MD
cord-024716-1waejlwb	102	26	be	be	VB
cord-024716-1waejlwb	102	27	confounding	confounding	JJ
cord-024716-1waejlwb	102	28	factors	factor	NNS
cord-024716-1waejlwb	102	29	.	.	.
cord-024716-1waejlwb	103	1	The	the	DT
cord-024716-1waejlwb	103	2	strain	strain	NN
cord-024716-1waejlwb	103	3	of	of	IN
cord-024716-1waejlwb	103	4	BCG	BCG	NNP
cord-024716-1waejlwb	103	5	used	use	VBN
cord-024716-1waejlwb	103	6	in	in	IN
cord-024716-1waejlwb	103	7	each	each	DT
cord-024716-1waejlwb	103	8	country	country	NN
cord-024716-1waejlwb	103	9	was	be	VBD
cord-024716-1waejlwb	103	10	not	not	RB
cord-024716-1waejlwb	103	11	taken	take	VBN
cord-024716-1waejlwb	103	12	to	to	IN
cord-024716-1waejlwb	103	13	consideration	consideration	NN
cord-024716-1waejlwb	103	14	.	.	.
cord-024716-1waejlwb	104	1	Different	different	JJ
cord-024716-1waejlwb	104	2	countries	country	NNS
cord-024716-1waejlwb	104	3	may	may	MD
cord-024716-1waejlwb	104	4	be	be	VB
cord-024716-1waejlwb	104	5	at	at	IN
cord-024716-1waejlwb	104	6	different	different	JJ
cord-024716-1waejlwb	104	7	stage	stage	NN
cord-024716-1waejlwb	104	8	of	of	IN
cord-024716-1waejlwb	104	9	the	the	DT
cord-024716-1waejlwb	104	10	pandemic	pandemic	NN
cord-024716-1waejlwb	104	11	at	at	IN
cord-024716-1waejlwb	104	12	the	the	DT
cord-024716-1waejlwb	104	13	time	time	NN
cord-024716-1waejlwb	104	14	of	of	IN
cord-024716-1waejlwb	104	15	writing	write	VBG
cord-024716-1waejlwb	104	16	the	the	DT
cord-024716-1waejlwb	104	17	article	article	NN
cord-024716-1waejlwb	104	18	.	.	.
cord-024716-1waejlwb	105	1	Hence	hence	RB
cord-024716-1waejlwb	105	2	,	,	,
cord-024716-1waejlwb	105	3	the	the	DT
cord-024716-1waejlwb	105	4	infection	infection	NN
cord-024716-1waejlwb	105	5	and	and	CC
cord-024716-1waejlwb	105	6	death	death	NN
cord-024716-1waejlwb	105	7	rates	rate	NNS
cord-024716-1waejlwb	105	8	may	may	MD
cord-024716-1waejlwb	105	9	increase	increase	VB
cord-024716-1waejlwb	105	10	in	in	IN
cord-024716-1waejlwb	105	11	some	some	DT
cord-024716-1waejlwb	105	12	countries	country	NNS
cord-024716-1waejlwb	105	13	in	in	IN
cord-024716-1waejlwb	105	14	future	future	NN
cord-024716-1waejlwb	105	15	.	.	.
cord-024716-1waejlwb	106	1	From	from	IN
cord-024716-1waejlwb	106	2	the	the	DT
cord-024716-1waejlwb	106	3	study	study	NN
cord-024716-1waejlwb	106	4	,	,	,
cord-024716-1waejlwb	106	5	it	-PRON-	PRP
cord-024716-1waejlwb	106	6	is	be	VBZ
cord-024716-1waejlwb	106	7	concluded	conclude	VBN
cord-024716-1waejlwb	106	8	that	that	IN
cord-024716-1waejlwb	106	9	cross	cross	NN
cord-024716-1waejlwb	106	10	-	-	NN
cord-024716-1waejlwb	106	11	protection	protection	NN
cord-024716-1waejlwb	106	12	against	against	IN
cord-024716-1waejlwb	106	13	COVID-19	COVID-19	NNP
cord-024716-1waejlwb	106	14	by	by	IN
cord-024716-1waejlwb	106	15	the	the	DT
cord-024716-1waejlwb	106	16	BCG	BCG	NNP
cord-024716-1waejlwb	106	17	vaccination	vaccination	NN
cord-024716-1waejlwb	106	18	is	be	VBZ
cord-024716-1waejlwb	106	19	a	a	DT
cord-024716-1waejlwb	106	20	very	very	RB
cord-024716-1waejlwb	106	21	strong	strong	JJ
cord-024716-1waejlwb	106	22	possibility	possibility	NN
cord-024716-1waejlwb	106	23	and	and	CC
cord-024716-1waejlwb	106	24	hence	hence	RB
cord-024716-1waejlwb	106	25	it	-PRON-	PRP
cord-024716-1waejlwb	106	26	must	must	MD
cord-024716-1waejlwb	106	27	be	be	VB
cord-024716-1waejlwb	106	28	properly	properly	RB
cord-024716-1waejlwb	106	29	explored	explore	VBN
cord-024716-1waejlwb	106	30	through	through	IN
cord-024716-1waejlwb	106	31	randomized	randomized	JJ
cord-024716-1waejlwb	106	32	controlled	control	VBN
cord-024716-1waejlwb	106	33	trials	trial	NNS
cord-024716-1waejlwb	106	34	.	.	.
cord-024716-1waejlwb	107	1	Besides	besides	RB
cord-024716-1waejlwb	107	2	,	,	,
cord-024716-1waejlwb	107	3	a	a	DT
cord-024716-1waejlwb	107	4	prevalence	prevalence	NN
cord-024716-1waejlwb	107	5	of	of	IN
cord-024716-1waejlwb	107	6	mycobacterial	mycobacterial	JJ
cord-024716-1waejlwb	107	7	infections	infection	NNS
cord-024716-1waejlwb	107	8	(	(	-LRB-
cord-024716-1waejlwb	107	9	either	either	CC
cord-024716-1waejlwb	107	10	by	by	IN
cord-024716-1waejlwb	107	11	BCG	BCG	NNP
cord-024716-1waejlwb	107	12	or	or	CC
cord-024716-1waejlwb	107	13	by	by	IN
cord-024716-1waejlwb	107	14	latent	latent	JJ
cord-024716-1waejlwb	107	15	/	/	SYM
cord-024716-1waejlwb	107	16	subclinical	subclinical	JJ
cord-024716-1waejlwb	107	17	/	/	SYM
cord-024716-1waejlwb	107	18	clinical	clinical	JJ
cord-024716-1waejlwb	107	19	tuberculosis	tuberculosis	NN
cord-024716-1waejlwb	107	20	)	)	-RRB-
cord-024716-1waejlwb	107	21	may	may	MD
cord-024716-1waejlwb	107	22	also	also	RB
cord-024716-1waejlwb	107	23	possibly	possibly	RB
cord-024716-1waejlwb	107	24	contribute	contribute	VB
cord-024716-1waejlwb	107	25	to	to	IN
cord-024716-1waejlwb	107	26	some	some	DT
cord-024716-1waejlwb	107	27	protection	protection	NN
cord-024716-1waejlwb	107	28	against	against	IN
cord-024716-1waejlwb	107	29	COVID-19	COVID-19	NNP
cord-024716-1waejlwb	107	30	.	.	.
cord-024716-1waejlwb	108	1	Patient	Patient	NNP
cord-024716-1waejlwb	108	2	's	's	POS
cord-024716-1waejlwb	108	3	consent	consent	NN
cord-024716-1waejlwb	108	4	not	not	RB
cord-024716-1waejlwb	108	5	required	require	VBN
cord-024716-1waejlwb	108	6	as	as	IN
cord-024716-1waejlwb	108	7	the	the	DT
cord-024716-1waejlwb	108	8	patient	patient	NN
cord-024716-1waejlwb	108	9	's	's	POS
cord-024716-1waejlwb	108	10	identity	identity	NN
cord-024716-1waejlwb	108	11	is	be	VBZ
cord-024716-1waejlwb	108	12	not	not	RB
cord-024716-1waejlwb	108	13	disclosed	disclose	VBN
cord-024716-1waejlwb	108	14	or	or	CC
cord-024716-1waejlwb	108	15	compromised	compromise	VBN
cord-024716-1waejlwb	108	16	.	.	.
cord-024716-1waejlwb	109	1	Nil	Nil	NNP
cord-024716-1waejlwb	109	2	.	.	.
cord-024716-1waejlwb	110	1	There	there	EX
cord-024716-1waejlwb	110	2	are	be	VBP
cord-024716-1waejlwb	110	3	no	no	DT
cord-024716-1waejlwb	110	4	conflicts	conflict	NNS
cord-024716-1waejlwb	110	5	of	of	IN
cord-024716-1waejlwb	110	6	interest	interest	NN
cord-024716-1waejlwb	110	7	.	.	.
cord-024716-1waejlwb	111	1	COVID-19	COVID-19	NNP
cord-024716-1waejlwb	111	2	Coronavirus	Coronavirus	NNP
cord-024716-1waejlwb	111	3	Pandemic	Pandemic	NNP
cord-024716-1waejlwb	111	4	Can	Can	MD
cord-024716-1waejlwb	111	5	an	an	DT
cord-024716-1waejlwb	111	6	Old	Old	NNP
cord-024716-1waejlwb	111	7	Vaccine	vaccine	NN
cord-024716-1waejlwb	111	8	Stop	stop	VB
cord-024716-1waejlwb	111	9	the	the	DT
cord-024716-1waejlwb	111	10	New	New	NNP
cord-024716-1waejlwb	111	11	Coronavirus	Coronavirus	NNP
cord-024716-1waejlwb	111	12	?	?	.
cord-024716-1waejlwb	112	1	The	the	DT
cord-024716-1waejlwb	112	2	New	New	NNP
cord-024716-1waejlwb	112	3	York	York	NNP
cord-024716-1waejlwb	112	4	Times	Times	NNP
cord-024716-1waejlwb	112	5	Non	non	JJ
cord-024716-1waejlwb	112	6	-	-	JJ
cord-024716-1waejlwb	112	7	specific	specific	JJ
cord-024716-1waejlwb	112	8	effects	effect	NNS
cord-024716-1waejlwb	112	9	of	of	IN
cord-024716-1waejlwb	112	10	BCG	BCG	NNP
cord-024716-1waejlwb	112	11	vaccine	vaccine	NN
cord-024716-1waejlwb	112	12	on	on	IN
cord-024716-1waejlwb	112	13	viral	viral	JJ
cord-024716-1waejlwb	112	14	infections	infection	NNS
cord-024716-1waejlwb	112	15	Routine	routine	JJ
cord-024716-1waejlwb	112	16	vaccinations	vaccination	NNS
cord-024716-1waejlwb	112	17	and	and	CC
cord-024716-1waejlwb	112	18	child	child	NN
cord-024716-1waejlwb	112	19	survival	survival	NN
cord-024716-1waejlwb	112	20	:	:	:
cord-024716-1waejlwb	112	21	Follow	follow	VB
cord-024716-1waejlwb	112	22	up	up	RP
cord-024716-1waejlwb	112	23	study	study	NN
cord-024716-1waejlwb	112	24	in	in	IN
cord-024716-1waejlwb	112	25	Trained	trained	JJ
cord-024716-1waejlwb	112	26	immunity	immunity	NN
cord-024716-1waejlwb	112	27	:	:	:
cord-024716-1waejlwb	112	28	A	a	DT
cord-024716-1waejlwb	112	29	program	program	NN
cord-024716-1waejlwb	112	30	of	of	IN
cord-024716-1waejlwb	112	31	innate	innate	JJ
cord-024716-1waejlwb	112	32	immune	immune	JJ
cord-024716-1waejlwb	112	33	memory	memory	NN
cord-024716-1waejlwb	112	34	in	in	IN
cord-024716-1waejlwb	112	35	health	health	NN
cord-024716-1waejlwb	112	36	and	and	CC
cord-024716-1waejlwb	112	37	disease	disease	NN
cord-024716-1waejlwb	112	38	Long	long	RB
cord-024716-1waejlwb	112	39	-	-	HYPH
cord-024716-1waejlwb	112	40	lasting	last	VBG
cord-024716-1waejlwb	112	41	effects	effect	NNS
cord-024716-1waejlwb	112	42	of	of	IN
cord-024716-1waejlwb	112	43	BCG	BCG	NNP
cord-024716-1waejlwb	112	44	vaccination	vaccination	NN
cord-024716-1waejlwb	112	45	on	on	IN
cord-024716-1waejlwb	112	46	both	both	CC
cord-024716-1waejlwb	112	47	heterologous	heterologous	NNP
cord-024716-1waejlwb	113	1	Th1	Th1	NNP
cord-024716-1waejlwb	113	2	/	/	SYM
cord-024716-1waejlwb	113	3	Th17	th17	CD
cord-024716-1waejlwb	113	4	responses	response	NNS
cord-024716-1waejlwb	113	5	and	and	CC
cord-024716-1waejlwb	113	6	innate	innate	JJ
cord-024716-1waejlwb	113	7	trained	train	VBN
cord-024716-1waejlwb	113	8	immunity	immunity	NN
cord-024716-1waejlwb	114	1	New	new	JJ
cord-024716-1waejlwb	114	2	live	live	JJ
cord-024716-1waejlwb	114	3	attenuated	attenuated	JJ
cord-024716-1waejlwb	114	4	tuberculosis	tuberculosis	NN
cord-024716-1waejlwb	114	5	vaccine	vaccine	NN
cord-024716-1waejlwb	114	6	MTBVAC	MTBVAC	NNP
cord-024716-1waejlwb	114	7	induces	induce	VBZ
cord-024716-1waejlwb	114	8	trained	train	VBN
cord-024716-1waejlwb	114	9	immunity	immunity	NN
cord-024716-1waejlwb	114	10	and	and	CC
cord-024716-1waejlwb	114	11	confers	confer	VBZ
cord-024716-1waejlwb	114	12	protection	protection	NN
cord-024716-1waejlwb	114	13	against	against	IN
cord-024716-1waejlwb	114	14	experimental	experimental	JJ
cord-024716-1waejlwb	114	15	lethal	lethal	JJ
cord-024716-1waejlwb	114	16	pneumonia	pneumonia	NN
cord-024716-1waejlwb	115	1	Quiescent	quiescent	JJ
cord-024716-1waejlwb	115	2	haematopoietic	haematopoietic	JJ
cord-024716-1waejlwb	115	3	stem	stem	NN
cord-024716-1waejlwb	115	4	cells	cell	NNS
cord-024716-1waejlwb	115	5	are	be	VBP
cord-024716-1waejlwb	115	6	activated	activate	VBN
cord-024716-1waejlwb	115	7	by	by	IN
cord-024716-1waejlwb	115	8	IFNgamma	IFNgamma	NNP
cord-024716-1waejlwb	115	9	in	in	IN
cord-024716-1waejlwb	115	10	response	response	NN
cord-024716-1waejlwb	115	11	to	to	IN
cord-024716-1waejlwb	115	12	chronic	chronic	JJ
cord-024716-1waejlwb	115	13	infection	infection	NN
cord-024716-1waejlwb	115	14	Targeting	target	VBG
cord-024716-1waejlwb	115	15	innate	innate	JJ
cord-024716-1waejlwb	115	16	immunity	immunity	NN
cord-024716-1waejlwb	115	17	for	for	IN
cord-024716-1waejlwb	115	18	tuberculosis	tuberculosis	NN
cord-024716-1waejlwb	115	19	vaccination	vaccination	NN